Selective	O
activation	O
and	O
functional	O
significance	O
of	O
p38alpha	B-protein
mitogen-activated	I-protein
protein	I-protein
kinase	I-protein
in	O
lipopolysaccharide-stimulated	B-cell_line
neutrophils	I-cell_line
.	O

Activation	O
of	O
leukocytes	B-cell_type
by	O
proinflammatory	O
stimuli	O
selectively	O
initiates	O
intracellular	O
signal	O
transduction	O
via	O
sequential	O
phosphorylation	O
of	O
kinases	B-protein
.	O

Lipopolysaccharide	O
(	O
LPS	O
)	O
stimulation	O
of	O
human	B-cell_type
neutrophils	I-cell_type
is	O
known	O
to	O
result	O
in	O
activation	O
of	O
p38	B-protein
mitogen-activated	I-protein
protein	I-protein
kinase	I-protein
(	O
MAPk	B-protein
)	O
;	O
however	O
,	O
the	O
upstream	B-protein
activator	I-protein
(	O
s	O
)	O
of	O
p38	B-protein
MAPk	I-protein
is	O
unknown	O
,	O
and	O
consequences	O
of	O
p38	B-protein
MAPk	I-protein
activation	O
remain	O
largely	O
undefined	O
.	O

We	O
investigated	O
the	O
MAPk	B-protein
kinase	I-protein
(	O
MKK	B-protein
)	O
that	O
activates	O
p38	B-protein
MAPk	I-protein
in	O
response	O
to	O
LPS	O
,	O
the	O
p38	B-protein
MAPk	I-protein
isoforms	I-protein
that	O
are	O
activated	O
as	O
part	O
of	O
this	O
pathway	O
,	O
and	O
the	O
functional	O
responses	O
affected	O
by	O
p38	B-protein
MAPk	I-protein
activation	O
.	O

Although	O
MKK3	B-protein
,	O
MKK4	B-protein
,	O
and	O
MKK6	B-protein
all	O
activated	O
p38	B-protein
MAPk	I-protein
in	O
experimental	O
models	O
,	O
only	O
MKK3	B-protein
was	O
found	O
to	O
activate	O
recombinant	O
p38	B-protein
MAPk	I-protein
in	O
LPS-treated	O
neutrophils	O
.	O

Of	O
p38	B-protein
MAPk	I-protein
isoforms	I-protein
studied	O
,	O
only	O
p38alpha	B-protein
and	O
p38delta	B-protein
were	O
detected	O
in	O
neutrophils	B-cell_type
.	O

LPS	O
stimulation	O
selectively	O
activated	O
p38alpha	B-protein
.	O

Specific	O
inhibitors	O
of	O
p38alpha	B-protein
MAPk	I-protein
blocked	O
LPS-induced	O
adhesion	O
,	O
nuclear	O
factor-kappa	O
B	O
(	O
NF-kappaB	B-protein
)	O
activation	O
,	O
and	O
synthesis	O
of	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
.	O

Inhibition	O
of	O
p38alpha	B-protein
MAPk	I-protein
resulted	O
in	O
a	O
transient	O
decrease	O
in	O
TNF-alpha	B-RNA
mRNA	I-RNA
accumulation	O
but	O
persistent	O
loss	O
of	O
TNF-alpha	B-protein
synthesis	O
.	O

These	O
findings	O
support	O
a	O
pathway	O
by	O
which	O
LPS	O
stimulation	O
of	O
neutrophils	B-cell_type
results	O
in	O
activation	O
of	O
MKK3	B-protein
,	O
which	O
in	O
turn	O
activates	O
p38alpha	B-protein
MAPk	I-protein
,	O
ultimately	O
regulating	O
adhesion	O
,	O
NF-kappaB	B-protein
activation	O
,	O
enhanced	O
gene	O
expression	O
of	O
TNF-alpha	B-protein
,	O
and	O
regulation	O
of	O
TNF-alpha	B-protein
synthesis	O
.	O

Selective	NULL
activation	NULL
and	NULL
functional	NULL
significance	NULL
of	NULL
p380	NULL
.	NULL

mitogen-activated	NULL
protein	NULL
kinase	NULL
in	NULL
lipopolysaccharide-stimulated	NULL
neutrophils	NULL
Jerry	NULL
A.	NULL
Nick	NULL
,	NULL
``	NULL
Natalie	NULL
J.	NULL
Avdi	NULL
,	NULL
'	NULL
Scott	NULL
K.	NULL
Young	NULL
,	NULL
!	NULL

Lisa	NULL
A.	NULL
Lehman	NULL
,	NULL
!	NULL

Patrick	NULL
P.	NULL
McDonald	NULL
,	NULL
?	NULL

S.	NULL
Courtney	NULL
Frasch	NULL
,	NULL
``	NULL
Marcella	NULL
A.	NULL
Billstrom	NULL
,	NULL
``	NULL
Peter	NULL
M	NULL
Henson	NULL
,	NULL
*~	NULL
Gary	NULL
L.	NULL
Johnson	NULL
,	NULL
``	NULL
and	NULL
G.	NULL
Scott	NULL
Worthen	NULL
**	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
*Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Division	NULL
of	NULL
Basic	NULL
Sciences	NULL
,	NULL
and	NULL
*Program	NULL
in	NULL
Molecular	NULL
Signal	NULL
Transduction	NULL
,	NULL
National	NULL
Jewish	NULL
Medical	NULL
and	NULL
Research	NULL
Center	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80206	NULL
,	NULL
USA	NULL
$	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
and	NULL
Â©Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
University	NULL
of	NULL
Colorado	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80262	NULL
,	NULL
USA	NULL
Address	NULL
correspondence	NULL
to	NULL
:	NULL
Jerry	NULL
A.	NULL
Nick	NULL
,	NULL
National	NULL
Jewish	NULL
Medical	NULL
and	NULL
Research	NULL
Center	NULL
,	NULL
1400	NULL
Jackson	NULL
Street	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80206	NULL
,	NULL
USA	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
303	NULL
)	NULL
398-1420	NULL
;	NULL
Fax	NULL
:	NULL
(	NULL
303	NULL
)	NULL
398-1851	NULL
;	NULL
E-mail	NULL
:	NULL
nickj	NULL
@	NULL
njc.org	NULL
Received	NULL
for	NULL
publication	NULL
September	NULL
17	NULL
,	NULL
1998	NULL
,	NULL
and	NULL
accepted	NULL
in	NULL
revised	NULL
form	NULL
February	NULL
1	NULL
,	NULL
1999	NULL
.	NULL

Activation	NULL
of	NULL
leukocytes	NULL
by	NULL
proinflammatory	NULL
stimuli	NULL
selectively	NULL
initiates	NULL
intracellular	NULL
signal	NULL
transduction	NULL
via	NULL
sequential	NULL
phosphorylation	NULL
of	NULL
kinases	NULL
.	NULL

Lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
is	NULL
known	NULL
to	NULL
result	NULL
in	NULL
activation	NULL
of	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPk	NULL
)	NULL
;	NULL
however	NULL
,	NULL
the	NULL
upstream	NULL
activator	NULL
(	NULL
s	NULL
)	NULL
of	NULL
p38	NULL
MAPk	NULL
is	NULL
unknown	NULL
,	NULL
and	NULL
consequences	NULL
of	NULL
p38	NULL
MAPk	NULL
activation	NULL
remain	NULL
largely	NULL
undefined	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
MAPK	NULL
kinase	NULL
(	NULL
MKK	NULL
)	NULL
that	NULL
activates	NULL
p38	NULL
MAP	NULL
k	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
,	NULL
the	NULL
p38	NULL
MAPk	NULL
isoforms	NULL
that	NULL
are	NULL
activated	NULL
as	NULL
part	NULL
of	NULL
this	NULL
pathway	NULL
,	NULL
and	NULL
the	NULL
functional	NULL
responses	NULL
affected	NULL
by	NULL
p38	NULL
MAPk	NULL
activation	NULL
.	NULL

Although	NULL
MKK3	NULL
,	NULL
MKK4	NULL
,	NULL
and	NULL
MKK6	NULL
all	NULL
activated	NULL
p38	NULL
MAPk	NULL
in	NULL
experimental	NULL
models	NULL
,	NULL
only	NULL
MKK3	NULL
was	NULL
found	NULL
to	NULL
activate	NULL
recombinant	NULL
p38	NULL
MAPk	NULL
in	NULL
LPS-treated	NULL
neutrophils	NULL
.	NULL

Of	NULL
p38	NULL
MAPk	NULL
isoforms	NULL
studied	NULL
,	NULL
only	NULL
p38	NULL
(	NULL
and	NULL
p388	NULL
were	NULL
detected	NULL
in	NULL
neutrophils	NULL
.	NULL

LPS	NULL
stimulation	NULL
selectively	NULL
activated	NULL
p38	NULL
(	NULL
.	NULL

Specific	NULL
inhibitors	NULL
of	NULL
MAPk	NULL
blocked	NULL
LPS-induced	NULL
adhesion	NULL
,	NULL
nuclear	NULL
factor-kappa	NULL
B	NULL
(	NULL
NF-KB	NULL
)	NULL
activation	NULL
,	NULL
and	NULL
synthesis	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-0	NULL
(	NULL
TNF-Q	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
MAPk	NULL
resulted	NULL
in	NULL
a	NULL
transient	NULL
decrease	NULL
in	NULL
TNF-Q	NULL
mRNA	NULL
accumulation	NULL
but	NULL
persistent	NULL
loss	NULL
of	NULL
TNF-	NULL
&	NULL
synthesis	NULL
.	NULL

These	NULL
findings	NULL
support	NULL
a	NULL
pathway	NULL
by	NULL
which	NULL
LPS	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
MKK3	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
activates	NULL
p38G	NULL
MAPk	NULL
,	NULL
ultimately	NULL
regulating	NULL
adhesion	NULL
,	NULL
NF-KB	NULL
activation	NULL
,	NULL
enhanced	NULL
gene	NULL
expression	NULL
of	NULL
TNF-Q	NULL
,	NULL
and	NULL
regulation	NULL
of	NULL
TNF-Q	NULL
synthesis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

103:851-858	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Introduction	NULL
Stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
by	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
elicits	NULL
functional	NULL
responses	NULL
that	NULL
are	NULL
central	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
a	NULL
number	NULL
of	NULL
human	NULL
diseases	NULL
.	NULL

However	NULL
,	NULL
the	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
used	NULL
by	NULL
neutrophils	NULL
in	NULL
response	NULL
to	NULL
proinflammatory	NULL
stimuli	NULL
have	NULL
only	NULL
begun	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

The	NULL
recent	NULL
delineation	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
;	NULL
superfamily	NULL
provides	NULL
a	NULL
framework	NULL
within	NULL
which	NULL
the	NULL
response	NULL
of	NULL
neutrophils	NULL
to	NULL
LPS	NULL
can	NULL
be	NULL
understood	NULL
.	NULL

MAPks	NULL
are	NULL
highly	NULL
conserved	NULL
signaling	NULL
kinases	NULL
that	NULL
act	NULL
to	NULL
regulate	NULL
cell	NULL
growth	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
stress	NULL
responses	NULL
(	NULL
1	NULL
)	NULL
.	NULL

At	NULL
least	NULL
three	NULL
distinct	NULL
families	NULL
of	NULL
MAPks	NULL
exist	NULL
in	NULL
mammalian	NULL
cells	NULL
:	NULL
the	NULL
p42/44	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
(	NULL
ERK	NULL
)	NULL
MAPks	NULL
,	NULL
c-Jun	NULL
kinases	NULL
(	NULL
JNKs	NULL
)	NULL
,	NULL
and	NULL
p38	NULL
MAPk	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

Our	NULL
group	NULL
and	NULL
others	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
have	NULL
reported	NULL
that	NULL
p38	NULL
MAPk	NULL
is	NULL
activated	NULL
in	NULL
the	NULL
neutrophil	NULL
after	NULL
LPS	NULL
binding	NULL
to	NULL
CD14	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
neither	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPks	NULL
nor	NULL
JNKs	NULL
are	NULL
activated	NULL
by	NULL
LPS	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
5-7	NULL
)	NULL
Activation	NULL
of	NULL
a	NULL
MAPk	NULL
is	NULL
the	NULL
final	NULL
step	NULL
in	NULL
a	NULL
three-part	NULL
intracellular	NULL
signal	NULL
transduction	NULL
cascade	NULL
in	NULL
which	NULL
a	NULL
MAP/ERK	NULL
kinase	NULL
kinase	NULL
(	NULL
MEKK	NULL
)	NULL
or	NULL
Raf	NULL
activates	NULL
(	NULL
through	NULL
phosphorylation	NULL
)	NULL
a	NULL
MAP/ERK	NULL
kinase	NULL
(	NULL
MEK	NULL
or	NULL
MKK	NULL
)	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
phosphorylates	NULL
a	NULL
specific	NULL
tyrosine	NULL
and	NULL
threonine	NULL
residue	NULL
on	NULL
a	NULL
MAPk	NULL
(	NULL
1	NULL
)	NULL
.	NULL

At	NULL
least	NULL
three	NULL
members	NULL
of	NULL
the	NULL
MKK	NULL
superfamily	NULL
are	NULL
capable	NULL
of	NULL
activating	NULL
p38	NULL
MAPk	NULL
.	NULL

When	NULL
overexpressed	NULL
in	NULL
cell	NULL
lines	NULL
,	NULL
MKK3	NULL
(	NULL
also	NULL
termed	NULL
MEK3	NULL
)	NULL
,	NULL
MKK4	NULL
(	NULL
JNKK1	NULL
)	NULL
,	NULL
and	NULL
MKK6	NULL
(	NULL
MEK6	NULL
)	NULL
can	NULL
all	NULL
phosphorylate	NULL
and	NULL
activate	NULL
p38	NULL
MAPk	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Four	NULL
distinct	NULL
isoforms	NULL
of	NULL
p38	NULL
MAPk	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

The	NULL
originally	NULL
described	NULL
human	NULL
homolog	NULL
of	NULL
the	NULL
Saccharomyces	NULL
cerevisiae	NULL
HOG1	NULL
kinase	NULL
and	NULL
the	NULL
mouse	NULL
p38	NULL
MAPk	NULL
(	NULL
2	NULL
)	NULL
is	NULL
now	NULL
referred	NULL
to	NULL
as	NULL
p38Q	NULL
.	NULL

Subsequently	NULL
described	NULL
isoforms	NULL
include	NULL
p38	NULL
$	NULL
B	NULL
with	NULL
74	NULL
%	NULL
amino	NULL
acid	NULL
identity	NULL
to	NULL
p38	NULL
,	NULL
p38Y	NULL
(	NULL
60	NULL
%	NULL
identity	NULL
to	NULL
p38	NULL
(	NULL
)	NULL
,	NULL
and	NULL
p386	NULL
(	NULL
57	NULL
%	NULL
identity	NULL
to	NULL
p38	NULL
)	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
isoforms	NULL
share	NULL
a	NULL
common	NULL
TGY	NULL
motif	NULL
in	NULL
kinase	NULL
subdomain	NULL
VIII	NULL
,	NULL
where	NULL
phosphorylation	NULL
of	NULL
a	NULL
specific	NULL
threonine	NULL
and	NULL
tyrosine	NULL
residues	NULL
is	NULL
required	NULL
for	NULL
activation	NULL
.	NULL

Once	NULL
activated	NULL
,	NULL
the	NULL
p38	NULL
MAP	NULL
ks	NULL
appear	NULL
capable	NULL
of	NULL
further	NULL
signal	NULL
transduction	NULL
through	NULL
phosphorylation	NULL
of	NULL
kinases	NULL
,	NULL
as	NULL
well	NULL
as	NULL
by	NULL
modulating	NULL
functional	NULL
responses	NULL
through	NULL
phosphorylation	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
March	NULL
1999	NULL
|	NULL
Volume	NULL
103	NULL
|_	NULL
Number	NULL
6	NULL
851	NULL
852	NULL
MAPk-associated	NULL
protein	NULL
kinase-2	NULL
(	NULL
MAPKAP-K2	NULL
)	NULL
and	NULL
MAPKAP-K3	NULL
are	NULL
activated	NULL
directly	NULL
by	NULL
MAPk	NULL
,	NULL
and	NULL
they	NULL
in	NULL
turn	NULL
can	NULL
phosphorylate	NULL
heat	NULL
shock	NULL
protein	NULL
27	NULL
(	NULL
HSP27	NULL
)	NULL
(	NULL
3	NULL
,	NULL
6	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Transcription	NULL
factors	NULL
directly	NULL
phosphorylated	NULL
by	NULL
p38G	NULL
MAP	NULL
k	NULL
include	NULL
activated	NULL
transcription	NULL
factor-2	NULL
(	NULL
ATF-2	NULL
)	NULL
,	NULL
serum	NULL
response	NULL
factor	NULL
accessory	NULL
protein-1	NULL
,	NULL
and	NULL
myocyte	NULL
enhancer	NULL
factor	NULL
2C	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Most	NULL
of	NULL
our	NULL
understanding	NULL
of	NULL
signal	NULL
transduction	NULL
in	NULL
eukaryotic	NULL
cells	NULL
has	NULL
risen	NULL
from	NULL
elegant	NULL
transfection	NULL
studies	NULL
in	NULL
cell	NULL
lines	NULL
.	NULL

However	NULL
,	NULL
significant	NULL
differences	NULL
exist	NULL
between	NULL
the	NULL
activation	NULL
of	NULL
signaling	NULL
pathways	NULL
in	NULL
the	NULL
neutrophil	NULL
when	NULL
compared	NULL
with	NULL
monocytes	NULL
or	NULL
cell	NULL
lines	NULL
(	NULL
13	NULL
,	NULL
15	NULL
)	NULL
.	NULL

As	NULL
short-lived	NULL
,	NULL
terminally	NULL
differentiated	NULL
primary	NULL
cells	NULL
,	NULL
neutrophils	NULL
use	NULL
rapid	NULL
responses	NULL
independent	NULL
of	NULL
transcriptional	NULL
or	NULL
translational	NULL
mechanisms	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
limited	NULL
repertoire	NULL
of	NULL
synthetic	NULL
func-tions	NULL
.	NULL

Rapid	NULL
responses	NULL
to	NULL
LPS	NULL
include	NULL
actin	NULL
assembly	NULL
and	NULL
adherence	NULL
.	NULL

As	NULL
a	NULL
single	NULL
stimulus	NULL
,	NULL
LPS	NULL
is	NULL
ineffective	NULL
in	NULL
evoking	NULL
chemokinesis	NULL
,	NULL
chemotaxis	NULL
,	NULL
or	NULL
the	NULL
release	NULL
of	NULL
superoxide	NULL
anion	NULL
or	NULL
granular	NULL
enzymes	NULL
.	NULL

Functional	NULL
responses	NULL
to	NULL
LPS	NULL
that	NULL
depend	NULL
on	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
primarily	NULL
consist	NULL
of	NULL
the	NULL
release	NULL
of	NULL
cytokines	NULL
(	NULL
16	NULL
)	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
neutrophils	NULL
use	NULL
the	NULL
p38	NULL
MAPk	NULL
cascade	NULL
to	NULL
link	NULL
proinflammatory	NULL
stimuli	NULL
to	NULL
an	NULL
array	NULL
of	NULL
functional	NULL
responses	NULL
.	NULL

Additional	NULL
specificity	NULL
could	NULL
occur	NULL
through	NULL
selective	NULL
activation	NULL
of	NULL
MKK-family	NULL
members	NULL
and	NULL
p38	NULL
MAPk	NULL
isoforms	NULL
.	NULL

We	NULL
studied	NULL
the	NULL
immediate	NULL
upstream	NULL
signaling	NULL
events	NULL
leading	NULL
to	NULL
activation	NULL
of	NULL
p38	NULL
MAPk	NULL
,	NULL
the	NULL
relative	NULL
activation	NULL
of	NULL
four	NULL
p38	NULL
MAPk	NULL
isoforms	NULL
,	NULL
and	NULL
the	NULL
functional	NULL
consequences	NULL
of	NULL
p38	NULL
MAPk	NULL
activation	NULL
after	NULL
stimulation	NULL
with	NULL
LPS	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
LPS	NULL
via	NULL
CD14	NULL
initiates	NULL
a	NULL
signal	NULL
that	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
MKK3	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
phosphorylates	NULL
and	NULL
activates	NULL
p38	NULL
MAPk	NULL
.	NULL

Stimulation	NULL
with	NULL
LPS	NULL
failed	NULL
to	NULL
activate	NULL
p388	NULL
MAPk	NULL
,	NULL
and	NULL
p38B	NULL
and	NULL
p38Yy	NULL
were	NULL
not	NULL
detected	NULL
.	NULL

After	NULL
activation	NULL
,	NULL
p38G	NULL
MAPk	NULL
regulates	NULL
at	NULL
least	NULL
three	NULL
distinctly	NULL
different	NULL
functions	NULL
:	NULL
adhesion	NULL
,	NULL
activation	NULL
of	NULL
nuclear	NULL
factor-kappa	NULL
B	NULL
(	NULL
NF-KB	NULL
)	NULL
,	NULL
and	NULL
the	NULL
synthesis	NULL
of	NULL
TNF-	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
advance	NULL
our	NULL
understanding	NULL
of	NULL
an	NULL
intracellular	NULL
signaling	NULL
pathway	NULL
used	NULL
by	NULL
the	NULL
human	NULL
neutrophil	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

Methods	NULL
Materials	NULL
.	NULL

Endotoxin-free	NULL
reagents	NULL
and	NULL
plastics	NULL
were	NULL
used	NULL
in	NULL
all	NULL
experiments	NULL
.	NULL

Neutrophils	NULL
were	NULL
isolated	NULL
by	NULL
the	NULL
plasma	NULL
Percoll	NULL
method	NULL
(	NULL
17	NULL
)	NULL
and	NULL
resuspended	NULL
in	NULL
Krebs-Ringer	NULL
phosphate	NULL
buffer	NULL
with	NULL
0.2	NULL
%	NULL
dextrose	NULL
at	NULL
pH	NULL
7.2	NULL
,	NULL
or	NULL
in	NULL
RPMI-1640	NULL
culture	NULL
medium	NULL
(	NULL
BioWhittaker	NULL
,	NULL
Walkersville	NULL
,	NULL
Maryland	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
done	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
%	NULL
human	NULL
heat-inac-tivated	NULL
platelet-poor	NULL
plasma	NULL
.	NULL

Aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
Tris-HCL	NULL
,	NULL
Triton	NULL
X-100	NULL
,	NULL
Igepal	NULL
,	NULL
PMSF	NULL
,	NULL
EDTA	NULL
,	NULL
EGTA	NULL
,	NULL
NP-40	NULL
,	NULL
and	NULL
protein	NULL
A-Sepharose	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
Immunochemicals	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
,	NULL
USA	NULL
)	NULL
,	NULL
and	NULL
[	NULL
y-*P|ATP	NULL
was	NULL
purchased	NULL
from	NULL
Amersham	NULL
Life	NULL
Sciences	NULL
Inc.	NULL
(	NULL
Arlington	NULL
Heights	NULL
,	NULL
Illinois	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

SK	NULL
&	NULL
F86002	NULL
and	NULL
SB203580	NULL
were	NULL
provided	NULL
by	NULL
SmithKline	NULL
Beecham	NULL
Pharmaceuticals	NULL
(	NULL
King	NULL
of	NULL
Prussia	NULL
,	NULL
Pennsylvania	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

ATFE-21-110	NULL
and	NULL
recombinant	NULL
human	NULL
p38	NULL
MAPK	NULL
(	NULL
rhp38	NULL
MAPk	NULL
)	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
5	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Neutrophil	NULL
functional	NULL
assays	NULL
.	NULL

Neutrophil	NULL
adherence	NULL
and	NULL
actin	NULL
assembly	NULL
after	NULL
stimulation	NULL
with	NULL
LPS	NULL
were	NULL
measured	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Release	NULL
of	NULL
TNF-Q	NULL
was	NULL
quantified	NULL
by	NULL
immunoassay	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
Minnesota	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
inhibition	NULL
of	NULL
p38	NULL
MAPk	NULL
was	NULL
performed	NULL
by	NULL
incubation	NULL
of	NULL
neutrophils	NULL
in	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
of	NULL
SK	NULL
&	NULL
F86002	NULL
or	NULL
SB203580	NULL
for	NULL
60	NULL
min	NULL
at	NULL
37Â°C	NULL
.	NULL

Statistical	NULL
analysis	NULL
of	NULL
the	NULL
significance	NULL
of	NULL
concentration-dependent	NULL
inhibition	NULL
for	NULL
each	NULL
functional	NULL
response	NULL
was	NULL
performed	NULL
by	NULL
group	NULL
mean	NULL
values	NULL
compared	NULL
by	NULL
one-way	NULL
ANOVA	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
to	NULL
determine	NULL
activation	NULL
of	NULL
NF-KB	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
.	NULL

P38	NULL
MAPR	NULL
isoform	NULL
antibodies	NULL
.	NULL

Specific	NULL
antibodies	NULL
against	NULL
p380	NULL
,	NULL
p38B	NULL
,	NULL
p38y	NULL
,	NULL
and	NULL
p386	NULL
and	NULL
recombinant	NULL
proteins	NULL
for	NULL
each	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
H.	NULL
Lichenstein	NULL
(	NULL
Amgen	NULL
Inc.	NULL
,	NULL
Boulder	NULL
,	NULL
Colorado	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

Polyclonal	NULL
antisera	NULL
to	NULL
the	NULL
following	NULL
peptides	NULL
were	NULL
prepared	NULL
in	NULL
rabbits	NULL
:	NULL
p38G	NULL
(	NULL
aa341-a2360	NULL
)	NULL
,	NULL
p38B	NULL
(	NULL
aa346-aa364	NULL
)	NULL
,	NULL
p38Y	NULL
(	NULL
aa321-aa339	NULL
)	NULL
,	NULL
and	NULL
p386	NULL
(	NULL
aa	NULL
262-aa280	NULL
)	NULL
.	NULL

Peptides	NULL
were	NULL
conjugated	NULL
to	NULL
keyhole	NULL
limpet	NULL
hemocyanin	NULL
and	NULL
injected	NULL
with	NULL
CFA	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
antisera	NULL
were	NULL
also	NULL
generated	NULL
to	NULL
full-length	NULL
recombinant	NULL
GST-flag-p388	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
studies	NULL
,	NULL
IgG	NULL
was	NULL
purified	NULL
from	NULL
antiserum	NULL
using	NULL
the	NULL
ImmunoPure	NULL
IgG	NULL
(	NULL
Protein	NULL
A	NULL
)	NULL
Purification	NULL
Kit	NULL
(	NULL
Pierce	NULL
Chemical	NULL
Co.	NULL
,	NULL
Rockford	NULL
,	NULL
Illinois	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

Immune	NULL
depletion	NULL
and	NULL
immunoprecipitation	NULL
assays	NULL
.	NULL

Neutrophils	NULL
were	NULL
stimulated	NULL
and	NULL
lysed	NULL
(	NULL
20	NULL
mM	NULL
Tris-HCL	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.5	NULL
%	NULL
Igepal	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
NaF	NULL
,	NULL
0.2	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
)	NULL
.	NULL

P386	NULL
was	NULL
depleted	NULL
from	NULL
whole-cell	NULL
lysates	NULL
(	NULL
500	NULL
)	NULL
containing	NULL
100	NULL
jug	NULL
cellular	NULL
protein	NULL
combined	NULL
with	NULL
5	NULL
ug	NULL
purified	NULL
anti-full-length	NULL
p386	NULL
rotated	NULL
for	NULL
6	NULL
or	NULL
12	NULL
h	NULL
at	NULL
3Â°C	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
bound	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
30	NULL
jil	NULL
of	NULL
protein	NULL
A-Sepharose	NULL
and	NULL
rotated	NULL
for	NULL
an	NULL
additional	NULL
2	NULL
h	NULL
at	NULL
3Â°C	NULL
.	NULL

Bound	NULL
Sepharose	NULL
was	NULL
removed	NULL
by	NULL
centrifuga-tion	NULL
(	NULL
14,000	NULL
g	NULL
for	NULL
15	NULL
s	NULL
)	NULL
.	NULL

The	NULL
cleared	NULL
supernatants	NULL
were	NULL
submitted	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
p38	NULL
(	NULL
and	NULL
p386	NULL
bound	NULL
to	NULL
Sepharose	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
lysis	NULL
buffer	NULL
and	NULL
once	NULL
in	NULL
PBS	NULL
and	NULL
then	NULL
submitted	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Blots	NULL
were	NULL
probed	NULL
for	NULL
p38	NULL
(	NULL
using	NULL
an	NULL
anti-p38	NULL
(	NULL
(	NULL
C20	NULL
)	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
California	NULL
,	NULL
USA	NULL
)	NULL
and	NULL
for	NULL
p386	NULL
using	NULL
anti-p386	NULL
(	NULL
peptide	NULL
)	NULL
antisera	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
p38	NULL
(	NULL
and	NULL
p388	NULL
was	NULL
determined	NULL
by	NULL
immunoblotting	NULL
with	NULL
an	NULL
anti-phosphotyro-sine	NULL
antibody	NULL
(	NULL
clone	NULL
4610	NULL
;	NULL
Upstate	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
New	NULL
York	NULL
)	NULL
.	NULL

Kinase	NULL
activity	NULL
of	NULL
and	NULL
p388	NULL
MAPks	NULL
was	NULL
assayed	NULL
from	NULL
immunoprecipitated	NULL
samples	NULL
by	NULL
the	NULL
ability	NULL
to	NULL
phosphorylate	NULL
ATF-21-110	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
)	NULL
.	NULL

MKK	NULL
assays	NULL
.	NULL

Neutrophils	NULL
were	NULL
lysed	NULL
with	NULL
extract	NULL
buffer	NULL
(	NULL
5	NULL
)	NULL
and	NULL
combined	NULL
with	NULL
anti-MKK3	NULL
or	NULL
anti-MKK4	NULL
antibodies	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
)	NULL
for	NULL
immunoprecipitation	NULL
studies	NULL
.	NULL

Bound	NULL
Sepharose	NULL
was	NULL
resuspended	NULL
in	NULL
25	NULL
ul	NULL
of	NULL
kinase	NULL
mix	NULL
(	NULL
17	NULL
)	NULL
with	NULL
and	NULL
without	NULL
thp38	NULL
MAPk	NULL
.	NULL

Reactions	NULL
were	NULL
terminated	NULL
with	NULL
2	NULL
%	NULL
Laemmli	NULL
buffer	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
resolved	NULL
with	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
phosphor	NULL
screen	NULL
autoradiography	NULL
,	NULL
with	NULL
quantification	NULL
of	NULL
activity	NULL
by	NULL
ImageQuant	NULL
(	NULL
Storm	NULL
Optical	NULL
Scanner	NULL
;	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
California	NULL
,	NULL
USA	NULL
)	NULL
and	NULL
qualitative	NULL
analysis	NULL
of	NULL
kinase	NULL
presence	NULL
and	NULL
phosphorylation	NULL
by	NULL
immunoblotting	NULL
.	NULL

Antibodies	NULL
used	NULL
to	NULL
probe	NULL
for	NULL
MKK6	NULL
included	NULL
MEK-6	NULL
(	NULL
N-19	NULL
)	NULL
(	NULL
K-19	NULL
)	NULL
(	NULL
V-19	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
)	NULL
,	NULL
anti-phospho	NULL
MKK3/MKK6	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
Inc.	NULL
,	NULL
Beverly	NULL
,	NULL
Massachusetts	NULL
)	NULL
,	NULL
and	NULL
anti-MKK6	NULL
(	NULL
full	NULL
length	NULL
)	NULL
,	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Amgen	NULL
Inc.	NULL
(	NULL
Boulder	NULL
,	NULL
Colorado	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

Quantification	NULL
of	NULL
TNF-	NULL
mRNA	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
from	NULL
30	NULL
x	NULL
106	NULL
neutrophils	NULL
with	NULL
Trizol	NULL
Reagent	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Maryland	NULL
,	NULL
USA	NULL
)	NULL
,	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
,	NULL
and	NULL
further	NULL
purified	NULL
by	NULL
precipitation	NULL
with	NULL
LiCl	NULL
.	NULL

The	NULL
RNase	NULL
protection	NULL
assay	NULL
(	NULL
RPA	NULL
)	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
a	NULL
RiboQuant	NULL
multiprobe	NULL
kit	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
California	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

The	NULL
RNase-protected	NULL
duplexes	NULL
were	NULL
resolved	NULL
on	NULL
denaturing	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
quantified	NULL
by	NULL
phosphorimaging	NULL
and	NULL
autoradiography	NULL
.	NULL

Results	NULL
Coupled	NULL
activation	NULL
of	NULL
MKK3	NULL
and	NULL
p38	NULL
MAPk	NULL
in	NULL
LPS-stimulated	NULL
neutrophils	NULL
.	NULL

Because	NULL
MKK3	NULL
,	NULL
MKK4	NULL
,	NULL
and	NULL
MKK6	NULL
are	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
-	NULL
|	NULL
March	NULL
1999	NULL
|	NULL
Volume	NULL
103	NULL
|_	NULL
Number	NULL
6	NULL
a	NULL
b	NULL
C00	NULL
shp3	NULL
&	NULL
MAPK	NULL
-o-	NULL
4+	NULL
+	NULL
+	NULL
60	NULL
<	NULL
p	NULL
.	NULL

thp38	NULL
MAPK	NULL
-	NULL
-	NULL
4	NULL
$	NULL
+4	NULL
MKEK3	NULL
IP	NULL
es	NULL
so	NULL
&	NULL
``	NULL
R	NULL
m	NULL
x	NULL
kDa	NULL
U	NULL
OL	NULL
U	NULL
L	NULL
&	NULL
$	NULL
0	NULL
%	NULL
s	NULL
8	NULL
4	NULL
(	NULL
)	NULL
==	NULL
E	NULL
an	NULL
L	NULL
Eb	NULL
;	NULL
a	NULL
14	NULL
Â«	NULL
<	NULL
=	NULL
eye	NULL
w	NULL
-	NULL
iuks	NULL
:	NULL
g	NULL
30	NULL
a	NULL
?	NULL

?	NULL

?	NULL

30	NULL
#	NULL
:	NULL
5	NULL
%	NULL
,	NULL
28	NULL
-	NULL
$	NULL
4	NULL
m	NULL
tlhe	NULL
at	NULL
_	NULL
T	NULL
~	NULL
g	NULL
n	NULL
voL	NULL
t	NULL
L	NULL
%	NULL
,	NULL
U	NULL
OL	NULL
U	NULL
L	NULL
a	NULL
,	NULL
*	NULL
.	NULL

``	NULL
.	NULL

Figure	NULL
1	NULL
Coupled	NULL
assay	NULL
of	NULL
MKK3	NULL
activation	NULL
.	NULL

Neutrophils	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
!	NULL
)	NULL

for	NULL
20	NULL
min	NULL
at	NULL
37Â°C	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Phosphorylation	NULL
of	NULL
MKK3	NULL
.	NULL

MKK3	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
cell	NULL
lysates	NULL
of	NULL
LPS-stimulated	NULL
(	NULL
L	NULL
)	NULL
or	NULL
unstimulated	NULL
(	NULL
U	NULL
)	NULL
neutrophils	NULL
.	NULL

Lysates	NULL
were	NULL
submitted	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
with	NULL
an	NULL
anti-phosphorylated	NULL
MKK3	NULL
antibody	NULL
.	NULL

A	NULL
cell-free	NULL
mixture	NULL
that	NULL
did	NULL
not	NULL
contain	NULL
immunoprecipitated	NULL
MKK3	NULL
is	NULL
shown	NULL
to	NULL
control	NULL
for	NULL
intrinsic	NULL
activity	NULL
of	NULL
the	NULL
rthp38	NULL
MAPK	NULL
.	NULL

Blot	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Activation	NULL
of	NULL
MKK3	NULL
.	NULL

52P	NULL
phosphorylation	NULL
of	NULL
rhp38	NULL
MAPk	NULL
from	NULL
blots	NULL
was	NULL
quantified	NULL
by	NULL
phosphor	NULL
screen	NULL
autoradiography	NULL
.	NULL

Lysates	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
rhp38	NULL
MAPk	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
were	NULL
compared	NULL
with	NULL
lysates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
rhp38	NULL
MAPk	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
and	NULL
a	NULL
cell-free	NULL
control	NULL
to	NULL
demonstrate	NULL
specific	NULL
activation	NULL
of	NULL
MKK3	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
as	NULL
determined	NULL
by	NULL
2P	NULL
phosphorylation	NULL
of	NULL
rthp38	NULL
MAPk	NULL
.	NULL

(	NULL
Â¢	NULL
)	NULL
Coupled	NULL
activation	NULL
of	NULL
rhp38	NULL
MAPk	NULL
by	NULL
activated	NULL
MKK3	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
activated	NULL
MKK3	NULL
to	NULL
activate	NULL
rhp38	NULL
MAPk	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
phosphorylated	NULL
rhp38	NULL
MAPk	NULL
to	NULL
phosphorylate	NULL
the	NULL
substrate	NULL
ATF-21-110.Â°Â°P	NULL
phosphorylation	NULL
of	NULL
ATF-21-110	NULL
from	NULL
blots	NULL
was	NULL
quantified	NULL
by	NULL
phosphor	NULL
screen	NULL
autoradiography	NULL
.	NULL

Lysates	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
rhp38	NULL
MAPk	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
represent	NULL
baseline	NULL
phosphorylation	NULL
of	NULL
the	NULL
ATF-21-110	NULL
,	NULL
whereas	NULL
lysates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
rhp38	NULL
MAPk	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
demonstrate	NULL
increased	NULL
phosphorylation	NULL
of	NULL
ATF-21-110	NULL
via	NULL
coupled	NULL
activation	NULL
of	NULL
rthp38	NULL
MAPk	NULL
by	NULL
activated	NULL
MKK3	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

The	NULL
cell-free	NULL
control	NULL
quantifies	NULL
intrinsic	NULL
activity	NULL
of	NULL
the	NULL
rhp38	NULL
MAPK	NULL
and	NULL
is	NULL
equivalent	NULL
to	NULL
the	NULL
unstimulated	NULL
lysate	NULL
in	NULL
lane	NULL
3	NULL
.	NULL

Plots	NULL
depict	NULL
mean	NULL
values	NULL
and	NULL
SEM	NULL
from	NULL
three	NULL
consecutive	NULL
experiments	NULL
expressed	NULL
in	NULL
arbitrary	NULL
units	NULL
.	NULL

ATF	NULL
,	NULL
activated	NULL
transcription	NULL
factor	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
MAPK	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
;	NULL
MKK	NULL
,	NULL
MAPK	NULL
kinase	NULL
.	NULL

each	NULL
capable	NULL
of	NULL
activating	NULL
p38	NULL
MAPk	NULL
,	NULL
we	NULL
first	NULL
deter-	NULL
-	NULL
lamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
.	NULL

Neutrophils	NULL
mined	NULL
which	NULL
of	NULL
these	NULL
MKKs	NULL
activates	NULL
p38	NULL
MAPk	NULL
in	NULL
the	NULL
-	NULL
stimulated	NULL
with	NULL
LPS	NULL
demonstrated	NULL
phosphorylation	NULL
LPS-stimulated	NULL
neutrophil	NULL
.	NULL

Stimulated	NULL
neutrophils	NULL
-	NULL
of	NULL
MKK3	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
that	NULL
corresponded	NULL
to	NULL
activation	NULL
of	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
MKK3	NULL
was	NULL
recovered	NULL
by	NULL
immunopre-	NULL
-	NULL
MKK3	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
phosphorylation	NULL
of	NULL
rhp38	NULL
MAPk	NULL
cipitation	NULL
.	NULL

Activation	NULL
of	NULL
MKK3	NULL
was	NULL
determined	NULL
by	NULL
its	NULL
(	NULL
Fig	NULL
.	NULL

1b	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
p38	NULL
MAPk	NULL
requires	NULL
specific	NULL
phosphorylation	NULL
and	NULL
its	NULL
ability	NULL
to	NULL
phosphorylate	NULL
and	NULL
-	NULL
phosphorylation	NULL
of	NULL
the	NULL
Tyr	NULL
'	NULL
!	NULL

*	NULL
residue	NULL
.	NULL

Thus	NULL
,	NULL
to	NULL
prove	NULL
activate	NULL
rhp38	NULL
MAPk	NULL
.	NULL

Simultaneous	NULL
assessment	NULL
of	NULL
the	NULL
-	NULL
phosphorylation	NULL
of	NULL
rhp38	NULL
MAPk	NULL
by	NULL
MKK3	NULL
was	NULL
specif-activation	NULL
of	NULL
the	NULL
rhp38	NULL
MAPk	NULL
was	NULL
determined	NULL
ic	NULL
,	NULL
assessment	NULL
of	NULL
activation	NULL
of	NULL
rhp38	NULL
MAPK	NULL
was	NULL
through	NULL
its	NULL
ability	NULL
to	NULL
phosphorylate	NULL
ATF-2	NULL
.	NULL

The	NULL
required	NULL
.	NULL

Phosphorylation	NULL
of	NULL
rthp38	NULL
MAPk	NULL
by	NULL
MKK3	NULL
immunoprecipitated	NULL
MKK3	NULL
was	NULL
incubated	NULL
with	NULL
rhp38	NULL
-	NULL
resulted	NULL
in	NULL
its	NULL
activation	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
abil-MAPk	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ATF-2	NULL
and	NULL
[	NULL
*P|ATP	NULL
,	NULL
followed	NULL
-	NULL
ity	NULL
of	NULL
the	NULL
phosphorylated	NULL
rhp38	NULL
MAPk	NULL
to	NULL
in	NULL
turn	NULL
by	NULL
separation	NULL
with	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacry-	NULL
phosphorylate	NULL
ATF-2	NULL
(	NULL
Fig	NULL
.	NULL

1c	NULL
)	NULL
.	NULL

Restaining	NULL
of	NULL
the	NULL
a	NULL
MKK4	NULL
IP	NULL
o	NULL
_	NULL
,	NULL
b	NULL
_	NULL
anssmar	NULL
--	NULL
+++	NULL
â¬	NULL
_	NULL
thp38	NULL
MAPK	NULL
-	NULL
-	NULL
++	NULL
+	NULL
y*	NULL
Â®	NULL
``	NULL
e-kDa	NULL
-	NULL
U	NULL
L	NULL
U	NULL
L	NULL
C	NULL
$	NULL
08	NULL
Lo	NULL
so	NULL
&	NULL
l	NULL
g	NULL
:	NULL
48	NULL
~	NULL
use	NULL
we	NULL
oe	NULL
#	NULL
#	NULL
-	NULL
MEKK4	NULL
``	NULL
gi	NULL
``	NULL
Â«	NULL
Â»	NULL
an	NULL
an	NULL
ab	NULL
Â£5	NULL
m	NULL
is	NULL
sn	NULL
Ee	NULL
Â£4	NULL
34	NULL
#	NULL
3	NULL
zo	NULL
34	NULL
Â«	NULL
=	NULL
f	NULL
_	NULL
E	NULL
g.	NULL
10	NULL
s	NULL
10	NULL
a	NULL
8	NULL
0	NULL
i	NULL
r	NULL
Figure	NULL
2	NULL
Coupled	NULL
assay	NULL
of	NULL
MKK4	NULL
activation	NULL
.	NULL

Neutrophils	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
20	NULL
min	NULL
at	NULL
37Â°C	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Phosphorylation	NULL
of	NULL
MKK4	NULL
.	NULL

Under	NULL
identical	NULL
conditions	NULL
to	NULL
the	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
MKK4	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
cell	NULL
lysates	NULL
and	NULL
submitted	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
with	NULL
an	NULL
anti-phosphorylated	NULL
MKK4	NULL
antibody	NULL
.	NULL

Blot	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Activation	NULL
of	NULL
MKK4	NULL
.	NULL

Â°P	NULL
phosphorylation	NULL
of	NULL
rhp38	NULL
MAPk	NULL
from	NULL
blots	NULL
was	NULL
quantified	NULL
by	NULL
phosphor	NULL
screen	NULL
autoradiography	NULL
.	NULL

Lysates	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
rthp38	NULL
MAPk	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
were	NULL
compared	NULL
with	NULL
lysates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
rthp38	NULL
MAPk	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
and	NULL
a	NULL
cell-free	NULL
control	NULL
to	NULL
demonstrate	NULL
the	NULL
lack	NULL
of	NULL
specific	NULL
activation	NULL
of	NULL
MKK4	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
as	NULL
determined	NULL
by	NULL
*P	NULL
phosphorylation	NULL
of	NULL
rthp38	NULL
MAPk	NULL
.	NULL

(	NULL
e	NULL
)	NULL
Coupled	NULL
activation	NULL
of	NULL
rthp38	NULL
MAPk	NULL
by	NULL
MKK4	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
MKK4	NULL
to	NULL
activate	NULL
rhp38	NULL
MAPk	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
phosphorylated	NULL
rhp38	NULL
MAPk	NULL
to	NULL
phosphorylate	NULL
the	NULL
substrate	NULL
ATF-21-110	NULL
.	NULL

Lysates	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
rhp38	NULL
MAPk	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
represent	NULL
baseline	NULL
phosphorylation	NULL
of	NULL
the	NULL
ATF-21-110	NULL
,	NULL
whereas	NULL
lysates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
rthp38	NULL
MAPk	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
demonstrate	NULL
little	NULL
increase	NULL
in	NULL
phosphorylation	NULL
of	NULL
ATF-21-110	NULL
via	NULL
coupled	NULL
activation	NULL
of	NULL
rthp38	NULL
MAPk	NULL
by	NULL
MKK4	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

The	NULL
cell-free	NULL
control	NULL
quantifies	NULL
intrinsic	NULL
activity	NULL
of	NULL
the	NULL
rhp38	NULL
MAPk	NULL
and	NULL
is	NULL
equivalent	NULL
to	NULL
the	NULL
unstimulated	NULL
and	NULL
LPS-stimulated	NULL
lysates	NULL
in	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
.	NULL

Plots	NULL
depict	NULL
mean	NULL
values	NULL
and	NULL
SEM	NULL
from	NULL
three	NULL
consecutive	NULL
experiments	NULL
expressed	NULL
in	NULL
arbitrary	NULL
units	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
March	NULL
1999	NULL
|	NULL
Volume103	NULL
|	NULL
Number	NULL
6	NULL
853	NULL
immunoblot	NULL
with	NULL
an	NULL
anti-MKK3	NULL
antibody	NULL
confirmed	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
MKK3	NULL
were	NULL
immunoprecipitated	NULL
under	NULL
each	NULL
condition	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

MKK4	NULL
and	NULL
MKK6	NULL
do	NULL
not	NULL
mediate	NULL
p38	NULL
MAPk	NULL
activation	NULL
in	NULL
LPS-stimulated	NULL
neutrophils	NULL
.	NULL

Under	NULL
identical	NULL
conditions	NULL
,	NULL
MKK4	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
untreated	NULL
and	NULL
stimulated	NULL
neutrophils	NULL
.	NULL

A	NULL
detectable	NULL
increase	NULL
in	NULL
phosphorylation	NULL
of	NULL
MKK4	NULL
was	NULL
observed	NULL
in	NULL
neutrophils	NULL
exposed	NULL
to	NULL
LPS	NULL
when	NULL
compared	NULL
with	NULL
unstimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

However	NULL
,	NULL
no	NULL
significant	NULL
phosphorylation	NULL
of	NULL
p38	NULL
MAPk	NULL
by	NULL
MKK4	NULL
occurred	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
*Â°P	NULL
incorporation	NULL
into	NULL
rhp38	NULL
MAPk	NULL
(	NULL
Fig	NULL
.	NULL

2b	NULL
)	NULL
.	NULL

In	NULL
turn	NULL
,	NULL
no	NULL
significant	NULL
increase	NULL
in	NULL
rhp38	NULL
MAP	NULL
k	NULL
activity	NULL
was	NULL
seen	NULL
as	NULL
determined	NULL
by	NULL
*P	NULL
phosphorylation	NULL
of	NULL
ATF-2	NULL
(	NULL
Fig	NULL
.	NULL

2Â¢	NULL
)	NULL
.	NULL

MKK6	NULL
is	NULL
also	NULL
capable	NULL
of	NULL
robust	NULL
p38	NULL
MAPK	NULL
activation	NULL
;	NULL
however	NULL
,	NULL
MKK6	NULL
(	NULL
unlike	NULL
MKK3	NULL
and	NULL
MKK4	NULL
)	NULL
appears	NULL
to	NULL
have	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
cell-type	NULL
specificity	NULL
(	NULL
9	NULL
,	NULL
19	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
(	NULL
19	NULL
)	NULL
that	NULL
in	NULL
human	NULL
leukocytes	NULL
,	NULL
MKK6	NULL
gene	NULL
expression	NULL
is	NULL
undetectable	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
cDNA	NULL
encoding	NULL
MKK6	NULL
was	NULL
originally	NULL
isolated	NULL
from	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Western	NULL
blots	NULL
performed	NULL
on	NULL
neutrophil	NULL
whole-cell	NULL
lysates	NULL
using	NULL
a	NULL
panel	NULL
of	NULL
MKK6-specific	NULL
antibodies	NULL
(	NULL
see	NULL
Methods	NULL
)	NULL
failed	NULL
to	NULL
detect	NULL
the	NULL
protein	NULL
when	NULL
compared	NULL
with	NULL
myocyte	NULL
and	NULL
mono-cyte	NULL
lysates	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
MKK6	NULL
is	NULL
not	NULL
constitutively	NULL
expressed	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

LPS	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
p38	NULL
,	NULL
but	NULL
not	NULL
p388	NULL
,	NULL
MAPk	NULL
.	NULL

Western	NULL
blots	NULL
of	NULL
neutrophil	NULL
lysates	NULL
were	NULL
probed	NULL
with	NULL
antibodies	NULL
against	NULL
p38B	NULL
,	NULL
p38Y	NULL
,	NULL
and	NULL
p388	NULL
.	NULL

Immunoblotting	NULL
with	NULL
antisera	NULL
raised	NULL
against	NULL
a	NULL
19-base	NULL
peptide	NULL
of	NULL
p3868	NULL
demonstrated	NULL
a	NULL
single	NULL
band	NULL
of	NULL
the	NULL
appropriate	NULL
molecular	NULL
weight	NULL
.	NULL

Identification	NULL
of	NULL
this	NULL
band	NULL
as	NULL
p3868	NULL
was	NULL
supported	NULL
by	NULL
selective	NULL
immunodepletion	NULL
analysis	NULL
of	NULL
the	NULL
neutrophil	NULL
lysate	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
immunoblotting	NULL
with	NULL
antibodies	NULL
against	NULL
p38B	NULL
and	NULL
p38Yy	NULL
failed	NULL
to	NULL
reveal	NULL
the	NULL
presence	NULL
of	NULL
these	NULL
isoforms	NULL
(	NULL
data	NULL
not	NULL
Figure	NULL
3	NULL
LPS	NULL
stimulation	NULL
selectively	NULL
activates	NULL
p38	NULL
@	NULL
MAPk	NULL
,	NULL
but	NULL
not	NULL
p388	NULL
MAPk	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Identification	NULL
of	NULL
p388	NULL
MAPK	NULL
in	NULL
neutrophil	NULL
whole-cell	NULL
lysates	NULL
(	NULL
WCL	NULL
)	NULL
by	NULL
immunodepletion	NULL
.	NULL

Neutrophil	NULL
lysate	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
with	NULL
anti-peptide	NULL
p386	NULL
antisera	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Confirmation	NULL
of	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
p388	NULL
MAPK	NULL
band	NULL
was	NULL
achieved	NULL
by	NULL
immunoprecipitating	NULL
p38	NULL
from	NULL
the	NULL
lysate	NULL
using	NULL
a	NULL
purified	NULL
anti-full-length	NULL
p388	NULL
antibody	NULL
.	NULL

A	NULL
significant	NULL
decrease	NULL
in	NULL
the	NULL
proposed	NULL
p386	NULL
band	NULL
is	NULL
observed	NULL
after	NULL
6	NULL
h	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
12	NULL
h	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
of	NULL
immunodepletion	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Immunoprecipitation	NULL
of	NULL
p38	NULL
@	NULL
and	NULL
p388	NULL
MAPk	NULL
.	NULL

Neutrophils	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
for	NULL
25	NULL
min	NULL
at	NULL
37Â°C	NULL
(	NULL
L	NULL
)	NULL
,	NULL
H2O2	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
for	NULL
20	NULL
min	NULL
at	NULL
37Â°C	NULL
(	NULL
H	NULL
)	NULL
,	NULL
or	NULL
unstimulated	NULL
(	NULL
U	NULL
)	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
p38	NULL
@	NULL
and	NULL
p388	NULL
MAPk	NULL
were	NULL
immunoprecipitated	NULL
and	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Western	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
antisera	NULL
specific	NULL
for	NULL
p38	NULL
and	NULL
p388	NULL
MAPk	NULL
to	NULL
demonstrate	NULL
equivalent	NULL
amounts	NULL
of	NULL
immunoprecipitation	NULL
for	NULL
each	NULL
condition	NULL
studied	NULL
.	NULL

(	NULL
Â¢	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
p38	NULL
and	NULL
p388	NULL
MAPk	NULL
.	NULL

Blots	NULL
from	NULL
b	NULL
were	NULL
reprobed	NULL
with	NULL
an	NULL
anti-phos-photyrosine	NULL
antibody	NULL
capable	NULL
of	NULL
reacting	NULL
with	NULL
phosphorylated	NULL
tyrosine	NULL
residues	NULL
from	NULL
both	NULL
p38	NULL
(	NULL
and	NULL
p388	NULL
MAPk	NULL
.	NULL

(	NULL
d	NULL
)	NULL
Activation	NULL
of	NULL
p38	NULL
and	NULL
p388	NULL
MAPk	NULL
.	NULL

Neutrophils	NULL
subjected	NULL
to	NULL
identical	NULL
conditions	NULL
as	NULL
in	NULL
b	NULL
and	NULL
c	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
p38	NULL
@	NULL
and	NULL
p388	NULL
MAPk	NULL
was	NULL
immunoprecipitated	NULL
and	NULL
combined	NULL
with	NULL
ATF-21-110	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
*PJATP	NULL
.	NULL

The	NULL
peptide	NULL
was	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
the	NULL
degree	NULL
of	NULL
*P	NULL
phosphorylation	NULL
of	NULL
ATF-21-110	NULL
was	NULL
assessed	NULL
by	NULL
autoradiography	NULL
of	NULL
the	NULL
blot	NULL
.	NULL

Each	NULL
panel	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
consecutive	NULL
experiments	NULL
.	NULL

shown	NULL
)	NULL
.	NULL

Failure	NULL
to	NULL
detect	NULL
p38B	NULL
and	NULL
p38y	NULL
supports	NULL
earlier	NULL
reports	NULL
of	NULL
tissue	NULL
specificity	NULL
,	NULL
as	NULL
expression	NULL
of	NULL
and	NULL
p38Y	NULL
mRNA	NULL
is	NULL
negligible	NULL
in	NULL
peripheral	NULL
leukocytes	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Activation	NULL
and	NULL
phosphorylation	NULL
of	NULL
p38	NULL
(	NULL
and	NULL
p3868	NULL
were	NULL
assessed	NULL
simultaneously	NULL
in	NULL
lysates	NULL
from	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
LPS	NULL
or	NULL
H	NULL
;	NULL
0	NULL
;	NULL
.	NULL

Both	NULL
p38	NULL
and	NULL
p388	NULL
were	NULL
immunoprecipitated	NULL
from	NULL
cell	NULL
lysates	NULL
after	NULL
stimulation	NULL
and	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

A	NULL
Western	NULL
blot	NULL
probed	NULL
with	NULL
antibodies	NULL
against	NULL
p38	NULL
and	NULL
p388	NULL
demonstrated	NULL
equivalent	NULL
amounts	NULL
of	NULL
kinase	NULL
for	NULL
each	NULL
condition	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
then	NULL
restained	NULL
with	NULL
an	NULL
antibody	NULL
capable	NULL
of	NULL
detecting	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
p38	NULL
(	NULL
@	NULL
and	NULL
p388	NULL
(	NULL
Fig	NULL
.	NULL

3Â¢	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
previously	NULL
,	NULL
stimulation	NULL
with	NULL
LPS	NULL
or	NULL
H	NULL
,	NULL
O	NULL
;	NULL
resulted	NULL
in	NULL
significant	NULL
phosphorylation	NULL
of	NULL
p38	NULL
&	NULL
MAPk	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
LPS	NULL
failed	NULL
to	NULL
phosphorylate	NULL
p386	NULL
MAPk	NULL
.	NULL

H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
13388	NULL
when	NULL
transfected	NULL
into	NULL
cells	NULL
lines	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
was	NULL
seen	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
inducing	NULL
phosphorylation	NULL
of	NULL
p386	NULL
in	NULL
the	NULL
neutrophil	NULL
.	NULL

Activation	NULL
of	NULL
p380	NULL
and	NULL
p388	NULL
was	NULL
determined	NULL
by	NULL
immunoprecipitating	NULL
each	NULL
isoform	NULL
from	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
cells	NULL
and	NULL
combining	NULL
the	NULL
kinases	NULL
with	NULL
ATF-2	NULL
(	NULL
a	NULL
suitable	NULL
substrate	NULL
for	NULL
both	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
P	NULL
]	NULL
ATP	NULL
.	NULL

Corresponding	NULL
to	NULL
the	NULL
pattern	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
stimulation	NULL
with	NULL
LPS	NULL
failed	NULL
to	NULL
activate	NULL
13388	NULL
,	NULL
whereas	NULL
H	NULL
;	NULL
O	NULL
;	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
the	NULL
isoform	NULL
(	NULL
Fig	NULL
.	NULL

3d	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
under	NULL
the	NULL
conditions	NULL
studied	NULL
,	NULL
p38	NULL
alone	NULL
is	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
stimulation	NULL
of	NULL
the	NULL
neutrophil	NULL
.	NULL

Inhibition	NULL
of	NULL
p38	NULL
MAPR	NULL
selectively	NULL
modulates	NULL
rapid	NULL
neutrophil	NULL
responses	NULL
to	NULL
LPS	NULL
.	NULL

The	NULL
pyridinyl	NULL
imidazoles	NULL
,	NULL
SK	NULL
&	NULL
F86002	NULL
and	NULL
S	NULL
$	NULL
B203580	NULL
,	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
inhibit	NULL
p38	NULL
MAPk	NULL
activity	NULL
with	NULL
insignificant	NULL
effect	NULL
on	NULL
other	NULL
mammalian	NULL
signaling	NULL
kinases	NULL
(	NULL
4	NULL
,	NULL
11-13	NULL
,	NULL
17	NULL
)	NULL
.	NULL

$	NULL
B203580	NULL
is	NULL
now	NULL
recognized	NULL
to	NULL
inhibit	NULL
only	NULL
the	NULL
&	NULL
and	NULL
B	NULL
isoforms	NULL
of	NULL
p38	NULL
MAPk	NULL
(	NULL
11	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
functional	NULL
854	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
-	NULL
|	NULL
d	NULL
WCL	NULL
kDa	NULL
fr	NULL
4	NULL
Â«	NULL
aah	NULL
49-	NULL
s	NULL
34-I-	NULL
2	NULL
3	NULL
kDa	NULL
p38a	NULL
p38	NULL
Â«	NULL
--	NULL
ams	NULL
Gib	NULL
34-U	NULL
L	NULL
H	NULL
U	NULL
L	NULL
H	NULL
C	NULL
kDa	NULL
[	NULL
$	NULL
3801	NULL
11336	NULL
-	NULL
Wo	NULL
a	NULL
-	NULL
a	NULL
Â»	NULL
a	NULL
Â»	NULL
nag	NULL
34-T	NULL
L	NULL
HU	NULL
L	NULL
H	NULL
d	NULL
p38a	NULL
p38a	NULL
KM	NULL
--	NULL
wiÂ®-	NULL
ATF	NULL
2	NULL
;	NULL
U	NULL
L	NULL
HU	NULL
L	NULL
H	NULL
March	NULL
1999	NULL
|	NULL
Volume103	NULL
|	NULL
Number6	NULL
a	NULL
b	NULL
C	NULL
1.5	NULL
20	NULL
|	NULL
g	NULL
Â°Â°	NULL
=	NULL
14	NULL
8	NULL
<	NULL
um	NULL
ma	NULL
.	NULL

$	NULL
6	NULL
2	NULL
13	NULL
3	NULL
E	NULL
Â§	NULL
+	NULL
Â£100	NULL
5	NULL
ma	NULL
8	NULL
Â£	NULL
S	NULL
12	NULL
8	NULL
P	NULL
=	NULL
@	NULL
E	NULL
50	NULL
o	NULL
3	NULL
Z	NULL
Â©	NULL
qa	NULL
2	NULL
&	NULL
f	NULL
0	NULL
0	NULL
0.1	NULL
1	NULL
10	NULL
100	NULL
0	NULL
0.1	NULL
1	NULL
10	NULL
0	NULL
O01	NULL
1	NULL
10	NULL
100	NULL
Inhibitor	NULL
Concentration	NULL
(	NULL
uM	NULL
)	NULL
$	NULL
B203580	NULL
(	NULL
uM	NULL
)	NULL
Inhibitor	NULL
Concentration	NULL
(	NULL
uM	NULL
)	NULL
ravon	NULL
(	NULL
t	NULL
Figure	NULL
4	NULL
Effect	NULL
of	NULL
p380Â¢	NULL
MAPk	NULL
inhibition	NULL
on	NULL
LPS-induced	NULL
rapid	NULL
neutrophil	NULL
responses	NULL
.	NULL

Neutrophils	NULL
suspended	NULL
in	NULL
SK	NULL
&	NULL
F86002	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
or	NULL
$	NULL
B203580	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
over	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
for	NULL
60	NULL
min	NULL
at	NULL
37Â°C	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
at	NULL
37Â°C	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Effect	NULL
of	NULL
in	NULL
vivo	NULL
inhibition	NULL
of	NULL
p38	NULL
(	NULL
MAPk	NULL
on	NULL
actin	NULL
assembly	NULL
.	NULL

The	NULL
-fold	NULL
increase	NULL
in	NULL
relative	NULL
fluorescence	NULL
index	NULL
(	NULL
RF	NULL
)	NULL
of	NULL
LPS-stimulated	NULL
neutrophils	NULL
(	NULL
5	NULL
min	NULL
)	NULL
compared	NULL
with	NULL
unstimulated	NULL
cells	NULL
was	NULL
plotted	NULL
for	NULL
each	NULL
concentration	NULL
of	NULL
$	NULL
B203580	NULL
.	NULL

The	NULL
plot	NULL
represents	NULL
mean	NULL
activity	NULL
and	NULL
SEM	NULL
for	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
relationship	NULL
between	NULL
$	NULL
B203580	NULL
concentration	NULL
and	NULL
inhibition	NULL
of	NULL
actin	NULL
assembly	NULL
was	NULL
not	NULL
statistically	NULL
significant	NULL
(	NULL
P	NULL
=	NULL
0.55	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Effect	NULL
of	NULL
in	NULL
vivo	NULL
inhibition	NULL
of	NULL
p380Â¢	NULL
MAPk	NULL
on	NULL
neutrophil	NULL
adhesion	NULL
.	NULL

The	NULL
-fold	NULL
increase	NULL
in	NULL
adhesion	NULL
of	NULL
LPS-stimulated	NULL
neutrophils	NULL
(	NULL
30	NULL
min	NULL
)	NULL
compared	NULL
with	NULL
unstimulated	NULL
cells	NULL
was	NULL
plotted	NULL
for	NULL
each	NULL
concentration	NULL
of	NULL
inhibitor	NULL
.	NULL

The	NULL
plot	NULL
represents	NULL
mean	NULL
values	NULL
and	NULL
SEM	NULL
for	NULL
six	NULL
experiments	NULL
.	NULL

The	NULL
relationship	NULL
between	NULL
the	NULL
concentrations	NULL
of	NULL
SK	NULL
&	NULL
F86002	NULL
or	NULL
$	NULL
B203580	NULL
and	NULL
inhibition	NULL
of	NULL
adhesion	NULL
is	NULL
significant	NULL
(	NULL
P	NULL
<	NULL
0.0001	NULL
)	NULL
.	NULL

(	NULL
e	NULL
)	NULL
Effect	NULL
of	NULL
p38	NULL
(	NULL
Â¢	NULL
MAPk	NULL
inhibition	NULL
on	NULL
LPS-induced	NULL
release	NULL
of	NULL
TNF-	NULL
@	NULL
.	NULL

The	NULL
quantity	NULL
of	NULL
TNF-	NULL
@	NULL
released	NULL
per	NULL
10Â°	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
120	NULL
min	NULL
)	NULL
was	NULL
plotted	NULL
for	NULL
each	NULL
concentration	NULL
of	NULL
inhibitor	NULL
.	NULL

The	NULL
plot	NULL
represents	NULL
mean	NULL
values	NULL
and	NULL
SEM	NULL
of	NULL
three	NULL
consecutive	NULL
experiments	NULL
.	NULL

The	NULL
relationship	NULL
between	NULL
the	NULL
concentrations	NULL
of	NULL
SK	NULL
&	NULL
F86002	NULL
or	NULL
$	NULL
B203580	NULL
and	NULL
inhibition	NULL
of	NULL
TNF-Q	NULL
release	NULL
is	NULL
significant	NULL
(	NULL
P	NULL
<	NULL
0.0001	NULL
)	NULL
.	NULL

TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

responses	NULL
to	NULL
LPS	NULL
that	NULL
depend	NULL
on	NULL
p38G	NULL
MAPk	NULL
activation	NULL
,	NULL
neutrophils	NULL
were	NULL
pretreated	NULL
with	NULL
SK	NULL
&	NULL
F86002	NULL
or	NULL
$	NULL
B203580	NULL
followed	NULL
by	NULL
stimulation	NULL
with	NULL
LPS	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
neutrophils	NULL
to	NULL
assemble	NULL
F-actin	NULL
appears	NULL
to	NULL
be	NULL
largely	NULL
independent	NULL
of	NULL
p38	NULL
MAPk	NULL
activation	NULL
,	NULL
with	NULL
no	NULL
inhibitor	NULL
effect	NULL
noted	NULL
except	NULL
at	NULL
the	NULL
highest	NULL
concentration	NULL
studied	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
pretreatment	NULL
with	NULL
the	NULL
p38	NULL
MAPk	NULL
inhibitors	NULL
resulted	NULL
in	NULL
a	NULL
signifi-cant	NULL
,	NULL
concentration-dependent	NULL
decrease	NULL
in	NULL
neutrophil	NULL
adhesion	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
p38Q	NULL
MAPk	NULL
activation	NULL
downregulates	NULL
TNF-	NULL
&	NULL
gene	NULL
expression	NULL
and	NULL
release	NULL
in	NULL
LPS-stimulated	NULL
neutrophils	NULL
.	NULL

Inhibition	NULL
of	NULL
p38	NULL
MAPk	NULL
by	NULL
pyridinyl	NULL
imidazoles	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
reduce	NULL
TNF-Q	NULL
release	NULL
in	NULL
monocytes	NULL
and	NULL
certain	NULL
cell	NULL
lines	NULL
(	NULL
4	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
investigated	NULL
whether	NULL
p38G	NULL
MAPk	NULL
is	NULL
a	NULL
component	NULL
of	NULL
the	NULL
signaling	NULL
pathway	NULL
leading	NULL
to	NULL
TNF-Q	NULL
release	NULL
in	NULL
neutrophils	NULL
.	NULL

Cells	NULL
treated	NULL
with	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
of	NULL
either	NULL
SK	NULL
&	NULL
F86002	NULL
or	NULL
SB203580	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
LPS	NULL
,	NULL
and	NULL
subsequent	NULL
quantification	NULL
of	NULL
TNF-Q	NULL
release	NULL
was	NULL
performed	NULL
by	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
.	NULL

Both	NULL
p38	NULL
MAPk	NULL
inhibitors	NULL
reduced	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
the	NULL
ability	NULL
of	NULL
LPS	NULL
to	NULL
elicit	NULL
the	NULL
secretion	NULL
of	NULL
TNF-	NULL
@	NULL
(	NULL
Fig	NULL
.	NULL

4Â¢	NULL
)	NULL
.	NULL

In	NULL
view	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
release	NULL
of	NULL
cytokines	NULL
by	NULL
activated	NULL
neutrophils	NULL
is	NULL
preceded	NULL
by	NULL
enhanced	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
and	NULL
gene	NULL
expression	NULL
(	NULL
16	NULL
)	NULL
,	NULL
we	NULL
next	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
MAPk	NULL
inhibitors	NULL
toward	NULL
mRNA	NULL
and	NULL
TNF-Q	NULL
protein	NULL
accumulation	NULL
in	NULL
LPS-stimulated	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
inhibition	NULL
of	NULL
p38	NULL
(	NULL
MAPk	NULL
activation	NULL
might	NULL
modulate	NULL
TNF-	NULL
mRNA	NULL
steady-state	NULL
levels	NULL
in	NULL
LPS-stimulated	NULL
neutrophils	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
$	NULL
B203580	NULL
and	NULL
stimulated	NULL
with	NULL
LPS	NULL
for	NULL
30	NULL
and	NULL
60	NULL
min-utes	NULL
.	NULL

TNF-G	NULL
mRNA	NULL
was	NULL
quantified	NULL
by	NULL
RPA	NULL
.	NULL

Stimulation	NULL
with	NULL
LPS	NULL
elicited	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
TNF-	NULL
&	NULL
mRNA	NULL
,	NULL
which	NULL
could	NULL
be	NULL
detected	NULL
as	NULL
early	NULL
as	NULL
30	NULL
minutes	NULL
after	NULL
LPS	NULL
addition	NULL
.	NULL

Pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
$	NULL
B203580	NULL
caused	NULL
a	NULL
50	NULL
%	NULL
-60	NULL
%	NULL
inhibition	NULL
of	NULL
the	NULL
LPS-induced	NULL
TNF-Q	NULL
mRNA	NULL
accumulation	NULL
at	NULL
the	NULL
30-minute	NULL
time	NULL
point	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
a	NULL
and	NULL
b	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
effect	NULL
of	NULL
SB203580	NULL
on	NULL
TNF-OQ	NULL
mRNA	NULL
was	NULL
transient	NULL
:	NULL
it	NULL
was	NULL
no	NULL
longer	NULL
observed	NULL
by	NULL
60	NULL
minutes	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
a	NULL
and	NULL
b	NULL
)	NULL
or	NULL
at	NULL
later	NULL
times	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
inhibition	NULL
of	NULL
p38G	NULL
MAPk	NULL
resulted	NULL
in	NULL
a	NULL
posttranslational	NULL
block	NULL
of	NULL
processing	NULL
or	NULL
release	NULL
of	NULL
TNF-	NULL
,	NULL
we	NULL
quantified	NULL
cell-associated	NULL
TNF-	NULL
from	NULL
LPS-stimulated	NULL
cells	NULL
after	NULL
inhibition	NULL
of	NULL
p380	NULL
MAPk	NULL
.	NULL

Pretreatment	NULL
of	NULL
neutrophils	NULL
with	NULL
$	NULL
B20580	NULL
did	NULL
not	NULL
result	NULL
in	NULL
an	NULL
intracellular	NULL
or	NULL
membrane-associated	NULL
accumulation	NULL
of	NULL
TNF-	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
inhibition	NULL
of	NULL
p38	NULL
(	NULL
@	NULL
MAPk	NULL
downregulates	NULL
TNF-	NULL
release	NULL
by	NULL
acting	NULL
primarily	NULL
at	NULL
the	NULL
level	NULL
of	NULL
(	NULL
or	NULL
before	NULL
)	NULL
translation	NULL
.	NULL

Inhibition	NULL
of	NULL
p380	NULL
MAPk	NULL
activation	NULL
prevents	NULL
NF-KB	NULL
activation	NULL
in	NULL
LPS-stimulated	NULL
neutrophils	NULL
.	NULL

Stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
LPS	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
result	NULL
in	NULL
NF-xB	NULL
activation	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
this	NULL
transcription	NULL
factor	NULL
is	NULL
known	NULL
to	NULL
regulate	NULL
TNF-	NULL
gene	NULL
expression	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
.	NULL

We	NULL
therefore	NULL
investigated	NULL
whether	NULL
p38	NULL
MAPk	NULL
inhibition	NULL
might	NULL
modulate	NULL
NF-KB	NULL
activation	NULL
in	NULL
neutrophils	NULL
.	NULL

Cells	NULL
were	NULL
pretreated	NULL
with	NULL
SB203580	NULL
and	NULL
subsequently	NULL
stimulated	NULL
with	NULL
LPS	NULL
before	NULL
EMSA	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

LPS-induced	NULL
NF-KB	NULL
activation	NULL
was	NULL
almost	NULL
completely	NULL
inhibited	NULL
in	NULL
neutrophils	NULL
pretreated	NULL
with	NULL
the	NULL
p38	NULL
MAPk	NULL
inhibitor	NULL
(	NULL
Fig	NULL
.	NULL

62	NULL
)	NULL
.	NULL

The	NULL
possibility	NULL
that	NULL
SB203580	NULL
might	NULL
directly	NULL
interfere	NULL
with	NULL
NF-KB	NULL
binding	NULL
to	NULL
our	NULL
NF-KB	NULL
probe	NULL
was	NULL
ruled	NULL
out	NULL
because	NULL
incubation	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
LPS-treated	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
$	NULL
B203580	NULL
resulted	NULL
in	NULL
no	NULL
difference	NULL
in	NULL
DNA-binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

66	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
LPS-elicited	NULL
NF-KB	NULL
by	NULL
SB	NULL
203580	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
transient	NULL
decrease	NULL
in	NULL
TNF-Q	NULL
mRNA	NULL
accumulation	NULL
observed	NULL
in	NULL
LPS-stimulated	NULL
neutrophils	NULL
after	NULL
SB203580	NULL
pretreatment	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
March	NULL
1999	NULL
|	NULL
Volume	NULL
103	NULL
|_	NULL
Number	NULL
6	NULL
855	NULL
1.8	NULL
a	NULL
b	NULL
]	NULL
â¬	NULL
=o	NULL
foe	NULL
4	NULL
SB	NULL
203580	NULL
c	NULL
44	NULL
a	NULL
m	NULL
3	NULL
E	NULL
w	NULL
Â§	NULL
i	NULL
=	NULL
doit	NULL
a	NULL
â	NULL
Sn	NULL
TNF-co-	NULL
Â«	NULL
as	NULL
E	NULL
[	NULL
8	NULL
EL	NULL
:	NULL
3	NULL
.	NULL

with	NULL
3	NULL
|	NULL
Ã©	NULL
1	NULL
Â«	NULL
C	NULL
1	NULL
1	NULL
i	NULL
iC	NULL
E	NULL
1.8	NULL
R	NULL
0	NULL
0	NULL
30	NULL
30	NULL
60	NULL
60	NULL
â¬	NULL
Fa	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Â£0	NULL
Z	NULL
&	NULL
E-Food	NULL
i	NULL
R	NULL
as	NULL
b	NULL
0	NULL
_	NULL
,	NULL
.n	NULL
30	NULL
60	NULL
-	NULL
all	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
1h	NULL
,	NULL
bog	NULL
so	NULL
&	NULL
an	NULL
mo	NULL
Time	NULL
(	NULL
min	NULL
}	NULL
Figure	NULL
5	NULL
Quantification	NULL
of	NULL
mRNA	NULL
by	NULL
RPA	NULL
.	NULL

(	NULL
a	NULL
)	NULL
RPA	NULL
autoradiograph	NULL
of	NULL
mRNA	NULL
at	NULL
0	NULL
,	NULL
30	NULL
,	NULL
and	NULL
60	NULL
min	NULL
after	NULL
stimulation	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
at	NULL
37Â°C	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
and	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
$	NULL
B203580	NULL
(	NULL
10	NULL
LLM	NULL
)	NULL
.	NULL

An	NULL
increase	NULL
in	NULL
TNF-Q	NULL
mRNA	NULL
seen	NULL
after	NULL
30	NULL
min	NULL
of	NULL
stimulation	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
is	NULL
substantially	NULL
reduced	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
SB203580	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

At	NULL
60	NULL
min	NULL
,	NULL
the	NULL
quantity	NULL
of	NULL
TNF-	NULL
mRNA	NULL
in	NULL
the	NULL
untreated	NULL
and	NULL
$	NULL
B203580-treated	NULL
cells	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
is	NULL
equivalent	NULL
.	NULL

The	NULL
blot	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
consecutive	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Normalized	NULL
plot	NULL
of	NULL
TNF-	NULL
mRNA	NULL
synthesis	NULL
as	NULL
quantified	NULL
by	NULL
RPA	NULL
.	NULL

Amount	NULL
of	NULL
TNF-Q	NULL
mRNA	NULL
present	NULL
for	NULL
each	NULL
condition	NULL
was	NULL
expressed	NULL
as	NULL
a	NULL
fraction	NULL
of	NULL
GAPDH	NULL
present	NULL
for	NULL
each	NULL
sample	NULL
to	NULL
correct	NULL
for	NULL
potential	NULL
differences	NULL
in	NULL
sample	NULL
loading	NULL
.	NULL

Each	NULL
value	NULL
was	NULL
then	NULL
normalize	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
TNF-	NULL
mRNA	NULL
present	NULL
at	NULL
30	NULL
min	NULL
of	NULL
LPS	NULL
stimulation	NULL
in	NULL
the	NULL
untreated	NULL
neutrophils	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
to	NULL
correct	NULL
for	NULL
variability	NULL
in	NULL
response	NULL
between	NULL
donors	NULL
.	NULL

After	NULL
30	NULL
min	NULL
of	NULL
LPS	NULL
stimulation	NULL
,	NULL
SB203580-treated	NULL
neutrophils	NULL
(	NULL
closed	NULL
bar	NULL
)	NULL
demonstrated	NULL
42	NULL
%	NULL
of	NULL
the	NULL
TNF-	NULL
mRNA	NULL
present	NULL
in	NULL
the	NULL
untreated	NULL
cells	NULL
(	NULL
hatched	NULL
bar	NULL
)	NULL
.	NULL

After	NULL
60	NULL
min	NULL
of	NULL
stimulation	NULL
,	NULL
no	NULL
significant	NULL
difference	NULL
is	NULL
seen	NULL
.	NULL

The	NULL
panel	NULL
represents	NULL
mean	NULL
values	NULL
and	NULL
SEM	NULL
of	NULL
three	NULL
consecutive	NULL
experiments	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Release	NULL
of	NULL
TNF-Q	NULL
@	NULL
under	NULL
conditions	NULL
studied	NULL
.	NULL

TNF-	NULL
released	NULL
from	NULL
the	NULL
neutrophils	NULL
studied	NULL
in	NULL
b	NULL
was	NULL
assayed	NULL
.	NULL

The	NULL
quantity	NULL
of	NULL
TNF-	NULL
@	NULL
released	NULL
per	NULL
10Â°	NULL
neutrophils	NULL
was	NULL
plotted	NULL
for	NULL
each	NULL
time	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
closed	NULL
bars	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
hatched	NULL
bars	NULL
)	NULL
of	NULL
$	NULL
B203580	NULL
.	NULL

The	NULL
panel	NULL
represents	NULL
mean	NULL
values	NULL
and	NULL
SEM	NULL
of	NULL
the	NULL
three	NULL
consecutive	NULL
experiments	NULL
described	NULL
for	NULL
b.	NULL
GAPDH	NULL
,	NULL
glyc-eraldehyde	NULL
phosphate	NULL
dehydrogenase	NULL
;	NULL
RPA	NULL
,	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

Discussion	NULL
Stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
with	NULL
physiological	NULL
concentrations	NULL
of	NULL
LPS	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LPS-binding	NULL
protein	NULL
(	NULL
LBP	NULL
)	NULL
is	NULL
initiated	NULL
through	NULL
binding	NULL
of	NULL
CD14	NULL
.	NULL

Our	NULL
group	NULL
and	NULL
others	NULL
(	NULL
5	NULL
,	NULL
20	NULL
)	NULL
have	NULL
demonstrated	NULL
that	NULL
LPS-induced	NULL
activation	NULL
of	NULL
p38	NULL
MAPk	NULL
and	NULL
subsequent	NULL
release	NULL
of	NULL
TNF-Q	NULL
can	NULL
be	NULL
nearly	NULL
eliminated	NULL
by	NULL
blocking	NULL
the	NULL
binding	NULL
of	NULL
LPS	NULL
to	NULL
CD14	NULL
.	NULL

After	NULL
binding	NULL
of	NULL
the	NULL
LPS-LBP	NULL
complex	NULL
to	NULL
CD14	NULL
,	NULL
the	NULL
signal	NULL
must	NULL
pass	NULL
through	NULL
the	NULL
plasma	NULL
membrane	NULL
via	NULL
a	NULL
companion	NULL
membrane-spanning	NULL
protein	NULL
,	NULL
because	NULL
CD14	NULL
does	NULL
not	NULL
have	NULL
an	NULL
intracellular	NULL
component	NULL
.	NULL

Human	NULL
homologs	NULL
of	NULL
the	NULL
Toll	NULL
receptor	NULL
in	NULL
Drosophila	NULL
are	NULL
transmembrane	NULL
proteins	NULL
that	NULL
appear	NULL
capable	NULL
of	NULL
such	NULL
a	NULL
function	NULL
.	NULL

When	NULL
transfected	NULL
into	NULL
cell	NULL
lines	NULL
,	NULL
toll-like	NULL
receptor	NULL
(	NULL
TLR	NULL
)	NULL
2	NULL
promotes	NULL
LPS	NULL
signal	NULL
transduction	NULL
,	NULL
which	NULL
is	NULL
enhanced	NULL
by	NULL
coexpression	NULL
of	NULL
CD14	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
the	NULL
LPS-resistant	NULL
C3H/HeJ	NULL
and	NULL
C57BL/108cCr	NULL
strains	NULL
of	NULL
mice	NULL
,	NULL
inability	NULL
to	NULL
respond	NULL
to	NULL
LPS	NULL
has	NULL
been	NULL
attributed	NULL
to	NULL
mutations	NULL
in	NULL
the	NULL
gene	NULL
expressing	NULL
TLR4	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
TLRs	NULL
in	NULL
a	NULL
b	NULL
c	NULL
Unstimulated	NULL
nuclear	NULL
mo	NULL
-	NULL
extract	NULL
=-	NULL
+	NULL
=-	NULL
+	NULL
SB203580	NULL
=	NULL
-+	NULL
SB203580	NULL
-	NULL
25	NULL
&	NULL
_	NULL
20	NULL
a	NULL
$	NULL
2	NULL
,	NULL
8	NULL
=	NULL
15	NULL
=	NULL
sh	NULL
i	NULL
3	NULL
10	NULL
Â£	NULL
5	NULL
(	NULL
U	NULL
OU	NULL
OL	NULL
L	NULL
SB203580	NULL
-	NULL
4+	NULL
-~	NULL
+	NULL
Figure	NULL
6	NULL
Inhibition	NULL
of	NULL
NF-KB	NULL
activation	NULL
by	NULL
$	NULL
B203580-induced	NULL
inhibition	NULL
of	NULL
p38	NULL
(	NULL
Â¢	NULL
MAPk	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Effect	NULL
of	NULL
in	NULL
vivo	NULL
inhibition	NULL
of	NULL
p38	NULL
(	NULL
MAPk	NULL
on	NULL
NF-KB	NULL
activation	NULL
.	NULL

Neutrophils	NULL
were	NULL
suspended	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
$	NULL
B203580	NULL
(	NULL
10	NULL
LM	NULL
)	NULL
for	NULL
60	NULL
min	NULL
at	NULL
37Â°C	NULL
and	NULL
subsequently	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
20	NULL
min	NULL
at	NULL
37Â°C	NULL
or	NULL
left	NULL
unstimulated	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
then	NULL
prepared	NULL
and	NULL
analyzed	NULL
in	NULL
EMSA	NULL
using	NULL
an	NULL
NF-KB	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

This	NULL
blot	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
consecutive	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Lack	NULL
of	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
$	NULL
B203580	NULL
toward	NULL
the	NULL
binding	NULL
of	NULL
NF-KB	NULL
to	NULL
its	NULL
cognate	NULL
sequence	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
LPS-stimulated	NULL
neutrophils	NULL
were	NULL
coincubated	NULL
with	NULL
$	NULL
B203580	NULL
(	NULL
100	NULL
LLM	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
the	NULL
binding	NULL
mixture	NULL
,	NULL
before	NULL
EMSA	NULL
analysis	NULL
.	NULL

This	NULL
blot	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
consecutive	NULL
experiments	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Release	NULL
of	NULL
TNF-	NULL
at	NULL
the	NULL
time	NULL
of	NULL
NF-KB	NULL
activation	NULL
.	NULL

The	NULL
quantity	NULL
of	NULL
TNF-Q	NULL
released	NULL
per	NULL
10Â°	NULL
neutrophils	NULL
from	NULL
the	NULL
samples	NULL
studied	NULL
in	NULL
a	NULL
was	NULL
plotted	NULL
for	NULL
each	NULL
condition	NULL
.	NULL

Bars	NULL
depict	NULL
the	NULL
mean	NULL
value	NULL
and	NULL
SEM	NULL
of	NULL
TNF-	NULL
release	NULL
(	NULL
per	NULL
10Â°	NULL
neutrophils	NULL
)	NULL
from	NULL
three	NULL
independent	NULL
experiments.EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
NF-KB	NULL
,	NULL
nuclear	NULL
factor-kappa	NULL
B	NULL
.	NULL

856	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
March	NULL
1999	NULL
|	NULL
Volume103	NULL
|	NULL
Number	NULL
6	NULL
the	NULL
LPS-signaling	NULL
pathway	NULL
of	NULL
human	NULL
neutrophil	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Although	NULL
early	NULL
intracellular	NULL
signaling	NULL
events	NULL
in	NULL
this	NULL
pathway	NULL
remain	NULL
undefined	NULL
,	NULL
they	NULL
are	NULL
independent	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
do	NULL
not	NULL
utilize	NULL
Ras	NULL
,	NULL
Raf	NULL
,	NULL
MEKK-1	NULL
,	NULL
or	NULL
MEK1/MEK2Z	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Instead	NULL
,	NULL
we	NULL
now	NULL
show	NULL
that	NULL
LPS-induced	NULL
activation	NULL
of	NULL
p38	NULL
MAPk	NULL
occurs	NULL
via	NULL
MKK3	NULL
(	NULL
independent	NULL
of	NULL
MKK4	NULL
or	NULL
MKK6	NULL
)	NULL
.	NULL

Only	NULL
the	NULL
p38G	NULL
and	NULL
p388	NULL
MAPk	NULL
isoforms	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
neutrophil	NULL
,	NULL
and	NULL
only	NULL
p38	NULL
was	NULL
found	NULL
to	NULL
be	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
p38	NULL
MAPk	NULL
contributes	NULL
to	NULL
functional	NULL
responses	NULL
including	NULL
adhesion	NULL
,	NULL
NF-KB	NULL
activation	NULL
,	NULL
and	NULL
the	NULL
synthesis	NULL
of	NULL
TNF-	NULL
.	NULL

The	NULL
exact	NULL
role	NULL
of	NULL
p38G	NULL
MAPk	NULL
in	NULL
the	NULL
complex	NULL
series	NULL
of	NULL
events	NULL
that	NULL
lead	NULL
to	NULL
neutrophil	NULL
adhesion	NULL
is	NULL
not	NULL
known	NULL
,	NULL
but	NULL
because	NULL
adhesion	NULL
occurs	NULL
independent	NULL
of	NULL
protein	NULL
synthesis	NULL
,	NULL
this	NULL
regulation	NULL
is	NULL
likely	NULL
to	NULL
involve	NULL
the	NULL
phosphorylation	NULL
of	NULL
different	NULL
substrates	NULL
than	NULL
the	NULL
ones	NULL
affecting	NULL
the	NULL
release	NULL
of	NULL
TNF-	NULL
.	NULL

A	NULL
diagram	NULL
depicting	NULL
our	NULL
present	NULL
understanding	NULL
of	NULL
LPS-induced	NULL
intracellular	NULL
signaling	NULL
in	NULL
the	NULL
neutrophil	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Through	NULL
use	NULL
of	NULL
specific	NULL
p38	NULL
MAPk	NULL
inhibitors	NULL
such	NULL
as	NULL
SK	NULL
&	NULL
F	NULL
86002	NULL
and	NULL
S	NULL
$	NULL
B203580	NULL
,	NULL
several	NULL
functional	NULL
consequences	NULL
of	NULL
p380G	NULL
MAPk	NULL
activation	NULL
have	NULL
been	NULL
identi-fied	NULL
.	NULL

These	NULL
pyridinyl	NULL
imidazoles	NULL
have	NULL
been	NULL
shown	NULL
in	NULL
vitro	NULL
to	NULL
inhibit	NULL
specifically	NULL
the	NULL
&	NULL
and	NULL
B	NULL
isoforms	NULL
of	NULL
p38	NULL
MAP	NULL
,	NULL
with	NULL
negligible	NULL
effect	NULL
on	NULL
other	NULL
important	NULL
protein	NULL
kinases	NULL
and	NULL
phosphatases	NULL
(	NULL
4	NULL
,	NULL
11	NULL
,	NULL
12	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Like-wise	NULL
,	NULL
in	NULL
vivo	NULL
studies	NULL
in	NULL
whole	NULL
cells	NULL
demonstrated	NULL
inhibition	NULL
of	NULL
p38	NULL
MAPk	NULL
,	NULL
with	NULL
no	NULL
effect	NULL
on	NULL
activation	NULL
of	NULL
JNKs	NULL
and	NULL
p42	NULL
ERK	NULL
MAPks	NULL
(	NULL
4	NULL
,	NULL
12	NULL
)	NULL
.	NULL

At	NULL
higher	NULL
concen-trations	NULL
,	NULL
inhibition	NULL
of	NULL
certain	NULL
JNK	NULL
isoforms	NULL
may	NULL
occur	NULL
;	NULL
however	NULL
,	NULL
these	NULL
kinases	NULL
are	NULL
not	NULL
activated	NULL
by	NULL
LPS	NULL
in	NULL
the	NULL
neutrophil	NULL
under	NULL
our	NULL
experimental	NULL
conditions	NULL
(	NULL
13	NULL
)	NULL
.	NULL

In	NULL
human	NULL
neutrophils	NULL
,	NULL
inhibition	NULL
of	NULL
p38	NULL
MAPk	NULL
results	NULL
in	NULL
decreased	NULL
superoxide	NULL
anion	NULL
production	NULL
,	NULL
reduction	NULL
in	NULL
adhesion	NULL
and	NULL
chemotaxis	NULL
in	NULL
response	NULL
to	NULL
fMLP	NULL
(	NULL
17	NULL
,	NULL
23	NULL
)	NULL
,	NULL
and	NULL
obstruction	NULL
of	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-8	NULL
release	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
p38G	NULL
MAPk	NULL
activation	NULL
may	NULL
influence	NULL
at	NULL
least	NULL
two	NULL
regulatory	NULL
steps	NULL
in	NULL
the	NULL
synthesis	NULL
of	NULL
TNF-	NULL
@	NULL
.	NULL

Inhibition	NULL
of	NULL
LPS-induced	NULL
NF-KB	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
transient	NULL
decrease	NULL
in	NULL
TNF-Q	NULL
mRNA	NULL
accumulation	NULL
observed	NULL
in	NULL
LPS-stimulated	NULL
neutrophils	NULL
after	NULL
pretreatment	NULL
with	NULL
$	NULL
B203580	NULL
.	NULL

Thus	NULL
,	NULL
inhibition	NULL
of	NULL
transcriptional	NULL
events	NULL
might	NULL
represent	NULL
one	NULL
of	NULL
the	NULL
mechanisms	NULL
whereby	NULL
p380	NULL
MAPk	NULL
inhibitors	NULL
block	NULL
TNF-release	NULL
.	NULL

However	NULL
,	NULL
it	NULL
must	NULL
be	NULL
emphasized	NULL
that	NULL
the	NULL
decrease	NULL
in	NULL
TNF-	NULL
mRNA	NULL
levels	NULL
resulting	NULL
from	NULL
p38	NULL
MAPk	NULL
inhibition	NULL
is	NULL
only	NULL
observed	NULL
during	NULL
the	NULL
first	NULL
hour	NULL
of	NULL
LPS	NULL
stimulation	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
sustained	NULL
inhibition	NULL
of	NULL
TNF-	NULL
&	NULL
synthesis	NULL
resulting	NULL
from	NULL
p38	NULL
(	NULL
MAPk	NULL
blockade	NULL
must	NULL
involve	NULL
additional	NULL
mechanisms	NULL
,	NULL
and	NULL
it	NULL
raises	NULL
the	NULL
possibility	NULL
of	NULL
a	NULL
posttranscriptional	NULL
role	NULL
for	NULL
p380	NULL
MAPk	NULL
in	NULL
the	NULL
context	NULL
of	NULL
production	NULL
.	NULL

Consistent	NULL
with	NULL
our	NULL
data	NULL
,	NULL
a	NULL
number	NULL
of	NULL
studies	NULL
have	NULL
provided	NULL
evidence	NULL
for	NULL
transcriptional	NULL
and	NULL
translational	NULL
effects	NULL
of	NULL
p38	NULL
MAPk	NULL
.	NULL

In	NULL
cell	NULL
lines	NULL
,	NULL
p38	NULL
MAPk	NULL
inhibitors	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
downregulate	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
genes	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
LPS-induced	NULL
c-Jun	NULL
mRNA	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
14	NULL
)	NULL
,	NULL
TNF-	NULL
&	NULL
@	NULL
-induced	NULL
IL-6	NULL
mRNA	NULL
in	NULL
L929	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
,	NULL
and	NULL
IL-1-induced	NULL
prostaglandin	NULL
endoperoxide	NULL
synthase-2	NULL
mRNA	NULL
in	NULL
primary	NULL
monocytes	NULL
(	NULL
25	NULL
)	NULL
are	NULL
reduced	NULL
by	NULL
inhibition	NULL
of	NULL
p38	NULL
MAPk	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
the	NULL
genes	NULL
encoding	NULL
IL-6	NULL
,	NULL
TNF-	NULL
,	NULL
and	NULL
prostaglandin	NULL
endoperoxide	NULL
synthase-2	NULL
all	NULL
depend	NULL
on	NULL
NF-KB	NULL
(	NULL
albeit	NULL
to	NULL
varying	NULL
degrees	NULL
)	NULL
for	NULL
inducible	NULL
expression	NULL
(	NULL
26	NULL
)	NULL
and	NULL
that	NULL
both	NULL
p38	NULL
MAPk	NULL
and	NULL
ERK	NULL
MAPk	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
downregulate	NULL
TNF-	NULL
Â«	NULL
-induced	NULL
IL-6	NULL
gene	NULL
expression	NULL
by	NULL
interfering	NULL
with	NULL
NF-KB-dependent	NULL
transcription	NULL
in	NULL
L929	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
LPS-stimulated	NULL
IL-1	NULL
and	NULL
TNF-	NULL
production	NULL
by	NULL
p38	NULL
MAP	NULL
k	NULL
inhibitors	NULL
in	NULL
THP-1	NULL
cells	NULL
occurs	NULL
at	NULL
the	NULL
translational	NULL
level	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
SK	NULL
&	NULL
F86002	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
TNF-Q	NULL
mRNA	NULL
levels	NULL
but	NULL
instead	NULL
was	NULL
found	NULL
to	NULL
inhibit	NULL
TNF-	NULL
mRNA	NULL
translation	NULL
by	NULL
inducing	NULL
a	NULL
shift	NULL
of	NULL
TNF-OQ	NULL
mRNA	NULL
from	NULL
polysomes	NULL
(	NULL
actively	NULL
translated	NULL
)	NULL
to	NULL
free	NULL
mRNA	NULL
(	NULL
translationally	NULL
inactive	NULL
)	NULL
(	NULL
28	NULL
)	NULL
.	NULL

One	NULL
possible	NULL
mechanism	NULL
by	NULL
which	NULL
p38	NULL
MAPk	NULL
could	NULL
regulate	NULL
translation	NULL
could	NULL
be	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
MAPk-interacting	NULL
kinase	NULL
1	NULL
,	NULL
which	NULL
phosphorylates	NULL
eukaryotic	NULL
translation	NULL
initiation	NULL
factor	NULL
eIF-4E	NULL
(	NULL
29	NULL
)	NULL
and	NULL
is	NULL
known	NULL
to	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
translation	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Significant	NULL
differences	NULL
appear	NULL
to	NULL
exist	NULL
between	NULL
mono-cytes/macrophages	NULL
and	NULL
neutrophils	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
role	NULL
of	NULL
p38	NULL
MAPk	NULL
in	NULL
synthesis	NULL
.	NULL

Recent	NULL
reports	NULL
in	NULL
LPS-stimulated	NULL
RAW	NULL
264.7	NULL
cells	NULL
have	NULL
demonstrated	NULL
a	NULL
regulatory	NULL
effect	NULL
of	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
on	NULL
TNF-	NULL
tran	NULL
ARX	NULL
NARRARARRRRRRRNARRANAIAARIAARIARIARA	NULL
iene	NULL
new	NULL
iene	NULL
whan	NULL
evn	NULL
e	NULL
whe	NULL
w	NULL
MKK3	NULL
p380	NULL
.	NULL

MAP	NULL
kinase	NULL
re	NULL
ZI	NULL
transcription	NULL
|	NULL
==	NULL
@	NULL
Â»	NULL
-	NULL
translation	NULL
\	NULL
TNF-o	NULL
adhesion	NULL
Figure	NULL
7	NULL
oot	NULL
.	NULL

PIAA	NULL
oY	NULL
hva	NULL
ca	NULL
erea	NULL
Wh	NULL
in	NULL
ene	NULL
Ner	NULL
Scheme	NULL
depicting	NULL
proposed	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
and	NULL
functional	NULL
consequences	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
of	NULL
human	NULL
neutrophils	NULL
with	NULL
LPS	NULL
.	NULL

Binding	NULL
of	NULL
CD14	NULL
by	NULL
LPS	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LBP	NULL
initiates	NULL
a	NULL
signal	NULL
that	NULL
passes	NULL
though	NULL
a	NULL
transmembrane	NULL
spanning	NULL
protein	NULL
and	NULL
a	NULL
series	NULL
of	NULL
yet	NULL
unknown	NULL
upstream	NULL
signaling	NULL
events	NULL
,	NULL
leading	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
MKK3-p38	NULL
@	NULL
MAPk	NULL
cascade	NULL
.	NULL

The	NULL
activator	NULL
of	NULL
MKK3	NULL
in	NULL
this	NULL
cell	NULL
(	NULL
MEKK-X	NULL
)	NULL
is	NULL
not	NULL
known	NULL
.	NULL

Activation	NULL
of	NULL
p380	NULL
,	NULL
MAPK	NULL
then	NULL
results	NULL
in	NULL
rapid	NULL
responses	NULL
such	NULL
as	NULL
adhesion	NULL
and	NULL
activation	NULL
of	NULL
NF-KB	NULL
.	NULL

Synthesis	NULL
of	NULL
the	NULL
TNF-	NULL
@	NULL
peptide	NULL
is	NULL
also	NULL
dependent	NULL
on	NULL
p38	NULL
MAPk	NULL
activation	NULL
,	NULL
in	NULL
part	NULL
through	NULL
activation	NULL
of	NULL
NF-KB	NULL
,	NULL
but	NULL
primarily	NULL
through	NULL
regulation	NULL
of	NULL
translation	NULL
.	NULL

LBS	NULL
,	NULL
lipopolysaccharide-binding	NULL
protein	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
March	NULL
1999	NULL
|	NULL
Volume	NULL
103	NULL
|_	NULL
Number	NULL
6	NULL
857	NULL
858	NULL
scription	NULL
,	NULL
and	NULL
a	NULL
significant	NULL
role	NULL
of	NULL
the	NULL
MEKK1/MEKA/JNK	NULL
cascade	NULL
on	NULL
TNF-	NULL
@	NULL
translation	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
the	NULL
mast	NULL
cell	NULL
line	NULL
RBL-2H3	NULL
,	NULL
production	NULL
of	NULL
TNF-Q	NULL
is	NULL
linked	NULL
to	NULL
activation	NULL
of	NULL
p42	NULL
MAPk	NULL
,	NULL
but	NULL
not	NULL
p38	NULL
MAPk	NULL
(	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
human	NULL
monocytes	NULL
,	NULL
a	NULL
role	NULL
for	NULL
p38	NULL
MAPk	NULL
activation	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
TNF-0	NULL
and	NULL
IL-1	NULL
release	NULL
has	NULL
been	NULL
proposed	NULL
(	NULL
4	NULL
,	NULL
32	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
p42/44	NULL
(	NULL
ERK	NULL
)	NULL
MAPk	NULL
are	NULL
not	NULL
activated	NULL
in	NULL
human	NULL
neutrophils	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
5	NULL
,	NULL
7	NULL
)	NULL
and	NULL
that	NULL
the	NULL
ability	NULL
to	NULL
activate	NULL
JNKs	NULL
diminishes	NULL
as	NULL
HL-60	NULL
promyelocytic	NULL
cells	NULL
differentiate	NULL
into	NULL
neutrophils	NULL
(	NULL
15	NULL
)	NULL
.	NULL

These	NULL
differences	NULL
support	NULL
the	NULL
observation	NULL
that	NULL
MAPk	NULL
cascades	NULL
may	NULL
serve	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
pur-poses	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
cellular	NULL
context	NULL
and	NULL
upstream	NULL
regulation	NULL
(	NULL
1	NULL
)	NULL
.	NULL

A	NULL
growing	NULL
body	NULL
of	NULL
evidence	NULL
supports	NULL
the	NULL
conclusion	NULL
that	NULL
regulatory	NULL
influences	NULL
of	NULL
p38	NULL
MAPk	NULL
can	NULL
occur	NULL
independent	NULL
of	NULL
protein	NULL
synthesis	NULL
or	NULL
at	NULL
the	NULL
site	NULL
(	NULL
s	NULL
)	NULL
of	NULL
transcription	NULL
and/or	NULL
translation	NULL
to	NULL
varying	NULL
degrees	NULL
in	NULL
a	NULL
gene-specific	NULL
manner	NULL
.	NULL

Further	NULL
specificity	NULL
is	NULL
conferred	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
different	NULL
cell	NULL
types	NULL
to	NULL
use	NULL
the	NULL
MAPK	NULL
cascades	NULL
in	NULL
distinct	NULL
manners	NULL
in	NULL
response	NULL
to	NULL
identical	NULL
stimuli	NULL
.	NULL

These	NULL
results	NULL
underscore	NULL
the	NULL
importance	NULL
of	NULL
defining	NULL
signaling	NULL
pathways	NULL
under	NULL
physiological	NULL
conditions	NULL
in	NULL
primary	NULL
human	NULL
cells	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Carl	NULL
Manthey	NULL
for	NULL
technical	NULL
advice	NULL
and	NULL
encourage-ment	NULL
.	NULL

The	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grants	NULL
K08	NULL
HL-03657	NULL
,	NULL
HL-40784	NULL
,	NULL
HL-34303	NULL
,	NULL
HL-09640	NULL
,	NULL
and	NULL
GM-30324	NULL
.	NULL

P.P	NULL
.	NULL

McDonald	NULL
is	NULL
a	NULL
Centennial	NULL
Fellow	NULL
of	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
Canada	NULL
.	NULL

1	NULL
.	NULL

Cobb	NULL
,	NULL
M.H	NULL
.	NULL

,	NULL
and	NULL
Goldsmith	NULL
,	NULL
EJ	NULL
.	NULL

1995	NULL
.	NULL

How	NULL
MAP	NULL
kinases	NULL
are	NULL
regulat-ed	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:14843-14846	NULL
.	NULL

2	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Lee	NULL
,	NULL
J.-D.	NULL
,	NULL
Bibbs	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.J.	NULL
1994	NULL
.	NULL

A	NULL
MAP	NULL
kinase	NULL
targeted	NULL
by	NULL
endotoxin	NULL
and	NULL
hyperosmolarity	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Science	NULL
.	NULL

265:808-811	NULL
.	NULL

3	NULL
.	NULL

Rouse	NULL
,	NULL
J.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
kinase	NULL
cascade	NULL
triggered	NULL
by	NULL
chemical	NULL
stress	NULL
and	NULL
heat	NULL
shock	NULL
which	NULL
stimulates	NULL
MAPKAP-2	NULL
and	NULL
phosphorylation	NULL
of	NULL
the	NULL
small	NULL
heat	NULL
shock	NULL
proteins	NULL
.	NULL

Cell	NULL
.	NULL

78:1027-1037	NULL
.	NULL

4	NULL
.	NULL

Lee	NULL
,	NULL
J.C.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
protein	NULL
kinase	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
inflammatory	NULL
cytokine	NULL
biosynthesis	NULL
.	NULL

Nature	NULL
.	NULL

372:739-746	NULL
.	NULL

5	NULL
.	NULL

Nick	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
a	NULL
p38	NULL
MAPk	NULL
in	NULL
human	NULL
neutrophils	NULL
by	NULL
LPS	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:4867-4875	NULL
.	NULL

6	NULL
.	NULL

Nahas	NULL
,	NULL
N.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
a	NULL
new	NULL
MAPk	NULL
cascade	NULL
in	NULL
human	NULL
neutrophil	NULL
stimulated	NULL
with	NULL
various	NULL
ago-nists	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

318:247-253	NULL
.	NULL

7	NULL
.	NULL

Fouda	NULL
,	NULL
B.L	NULL
.	NULL

,	NULL
Molski	NULL
,	NULL
T.F.P	NULL
.	NULL

,	NULL
Ashour	NULL
,	NULL
M.S	NULL
.	NULL

,	NULL
and	NULL
Sha'afi	NULL
,	NULL
R1	NULL
.	NULL

1995	NULL
.	NULL

Effect	NULL
of	NULL
LPS	NULL
on	NULL
MAPks	NULL
and	NULL
cytosolic	NULL
phospholipase	NULL
AZ	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

308:815-822	NULL
.	NULL

8	NULL
.	NULL

DÃ©rijard	NULL
,	NULL
B.	NULL
,	NULL
etal	NULL
.	NULL

1995	NULL
.	NULL

Independent	NULL
human	NULL
MAP	NULL
kinase	NULL
signal	NULL
transduction	NULL
pathways	NULL
defined	NULL
by	NULL
MEK	NULL
and	NULL
MKK	NULL
isoforms	NULL
.	NULL

Science	NULL
.	NULL

267:682-685	NULL
.	NULL

9	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
ef	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
a	NULL
novel	NULL
MAPKK	NULL
(	NULL
MKK6	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:2886-2891	NULL
.	NULL

10	NULL
.	NULL

Wang	NULL
,	NULL
X.S	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
p38	NULL
MAPk	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:23688-23674	NULL
.	NULL

11	NULL
.	NULL

Goedert	NULL
,	NULL
M.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
novel	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
SAPKA4	NULL
by	NULL
cytokines	NULL
and	NULL
cellular	NULL
stresses	NULL
is	NULL
mediated	NULL
by	NULL
SKK3	NULL
(	NULL
MKK6	NULL
)	NULL
:	NULL
comparison	NULL
of	NULL
its	NULL
substrate	NULL
specificity	NULL
with	NULL
that	NULL
of	NULL
other	NULL
SAP	NULL
kinases	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16:3563-3571	NULL
.	NULL

12	NULL
.	NULL

Cuenda	NULL
,	NULL
A.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
.	NULL

SB	NULL
203580	NULL
is	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
a	NULL
MAPk	NULL
homologue	NULL
which	NULL
is	NULL
stimulated	NULL
by	NULL
cellular	NULL
stresses	NULL
and	NULL
interleukin-L.	NULL
FEBS	NULL
Lett	NULL
.	NULL

364:229-233	NULL
.	NULL

13	NULL
.	NULL

Whitmarsh	NULL
,	NULL
AJ	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Role	NULL
of	NULL
p38	NULL
and	NULL
JNK	NULL
MAPks	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
ternary	NULL
complex	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:2360-2372	NULL
.	NULL

14	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Jiang	NULL
,	NULL
Y.	NULL
,	NULL
Li	NULL
,	NULL
Z.	NULL
,	NULL
Kravchenko	NULL
,	NULL
V.V	NULL
.	NULL

,	NULL
and	NULL
Ulevtich	NULL
,	NULL
R.J.	NULL
1997	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
MEF2C	NULL
by	NULL
the	NULL
MAPk	NULL
p38	NULL
in	NULL
inflammation	NULL
.	NULL

Nature	NULL
.	NULL

386:296-299	NULL
.	NULL

15.Frasch	NULL
,	NULL
S.C.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998.	NULL
p38	NULL
MAPk-dependent	NULL
and	NULL
-independent	NULL
intracellular	NULL
signal	NULL
transduction	NULL
pathways	NULL
leading	NULL
to	NULL
apoptosis	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:8389-8397	NULL
.	NULL

16.Cassatella	NULL
,	NULL
M.	NULL
1995	NULL
.	NULL

The	NULL
production	NULL
of	NULL
cytokines	NULL
by	NULL
polymor-phonuclear	NULL
neutrophils	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

16-21	NULL
.	NULL

17	NULL
.	NULL

Nick	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Common	NULL
and	NULL
distinct	NULL
intracellular	NULL
signalling	NULL
pathways	NULL
in	NULL
human	NULL
neutrophil	NULL
utilized	NULL
by	NULL
platelet	NULL
activating	NULL
factor	NULL
and	NULL
FMLP	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

99:975-986	NULL
.	NULL

18	NULL
.	NULL

McDonald	NULL
,	NULL
P.P	NULL
.	NULL

,	NULL
Bald	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Cassatella	NULL
,	NULL
M.A	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
NF-kB	NULL
pathway	NULL
by	NULL
inflammatory	NULL
stimuli	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

Blood	NULL
.	NULL

89:3421-3433	NULL
.	NULL

19	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
Brady	NULL
,	NULL
H.	NULL
,	NULL
Yang	NULL
,	NULL
M.X	NULL
.	NULL

,	NULL
Young	NULL
,	NULL
D.B	NULL
.	NULL

,	NULL
and	NULL
Barbosa	NULL
,	NULL
M.S	NULL
.	NULL

1996	NULL
.	NULL

Cloning	NULL
and	NULL
characterization	NULL
of	NULL
mek6	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
MKK	NULL
cascade	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:11427-11433	NULL
.	NULL

20	NULL
.	NULL

Haziot	NULL
,	NULL
A.	NULL
,	NULL
Tsuberi	NULL
,	NULL
B.-Z	NULL
.	NULL

,	NULL
and	NULL
Goyert	NULL
,	NULL
S.M	NULL
.	NULL

1993	NULL
.	NULL

Neutrophil	NULL
CD14	NULL
:	NULL
biochemical	NULL
properties	NULL
and	NULL
role	NULL
in	NULL
the	NULL
secretion	NULL
of	NULL
TNF-	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:5556-5565	NULL
.	NULL

21	NULL
.	NULL

Yang	NULL
,	NULL
R.-B	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

TLR-2	NULL
mediates	NULL
LPS-induced	NULL
cellular	NULL
sig-nalling	NULL
.	NULL

Nature	NULL
.	NULL

395:284-288	NULL
.	NULL

22	NULL
.	NULL

Poltorak	NULL
,	NULL
A.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Defective	NULL
LPS	NULL
signaling	NULL
in	NULL
C3H/HeJ	NULL
and	NULL
C57BL/105cCr	NULL
mice	NULL
:	NULL
mutations	NULL
in	NULL
Tir4	NULL
gene	NULL
.	NULL

Science	NULL
.	NULL

282:2085-2088	NULL
.	NULL

23	NULL
.	NULL

Zu	NULL
,	NULL
Y.-L.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998.	NULL
p38	NULL
MAPk	NULL
Activation	NULL
is	NULL
required	NULL
for	NULL
human	NULL
neutrophil	NULL
function	NULL
triggered	NULL
by	NULL
TNF-G	NULL
or	NULL
FMLP	NULL
stimulation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:1982-1989	NULL
.	NULL

24	NULL
.	NULL

Beyaert	NULL
,	NULL
R.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
p38/RK	NULL
MAPk	NULL
pathway	NULL
regulates	NULL
IL-6	NULL
synthesis	NULL
in	NULL
response	NULL
to	NULL
TNF	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:1914-1923	NULL
.	NULL

25	NULL
.	NULL

Pouliot	NULL
,	NULL
M.	NULL
,	NULL
ef	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Inhibition	NULL
of	NULL
prostaglandin	NULL
endoperoxide	NULL
synthase-2	NULL
expression	NULL
in	NULL
stimulated	NULL
human	NULL
monocytes	NULL
by	NULL
inhibitors	NULL
of	NULL
p38	NULL
MAPk	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:4930-4937	NULL
.	NULL

26	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
and	NULL
Henkel	NULL
,	NULL
T.	NULL
1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-kappa	NULL
B	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Anne	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141-179	NULL
.	NULL

27	NULL
.	NULL

Berghe	NULL
,	NULL
W.V	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1998.	NULL
p38	NULL
and	NULL
ERK	NULL
MAPk	NULL
pathways	NULL
are	NULL
required	NULL
for	NULL
NF-kB	NULL
p65	NULL
transactivation	NULL
mediated	NULL
by	NULL
TNF	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:3285-3290	NULL
.	NULL

28	NULL
.	NULL

Prichett	NULL
,	NULL
W.	NULL
,	NULL
Hand	NULL
,	NULL
A.	NULL
,	NULL
Sheilds	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Dunningyon	NULL
,	NULL
D.	NULL
1995	NULL
.	NULL

Mechanism	NULL
of	NULL
action	NULL
of	NULL
bicyclic	NULL
imidazoles	NULL
defines	NULL
a	NULL
translational	NULL
regulatory	NULL
pathway	NULL
for	NULL
TNF-	NULL
.	NULL

J.	NULL
Inflamm	NULL
.	NULL

45:97-105	NULL
.	NULL

29	NULL
.	NULL

Waskiewicz	NULL
,	NULL
AJ	NULL
.	NULL

,	NULL
Flynn	NULL
,	NULL
A.	NULL
,	NULL
Proud	NULL
,	NULL
C.G	NULL
.	NULL

,	NULL
and	NULL
Cooper	NULL
,	NULL
A.J	NULL
.	NULL

1997	NULL
.	NULL

MAPks	NULL
activate	NULL
the	NULL
serine/threonine	NULL
kinases	NULL
Mnk1	NULL
and	NULL
Mnk2	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16:1909-1920	NULL
.	NULL

30	NULL
.	NULL

Swantek	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Cobb	NULL
,	NULL
M.H	NULL
.	NULL

,	NULL
and	NULL
Geppert	NULL
,	NULL
TD	NULL
.	NULL

1997	NULL
.	NULL

JNK/SAPK	NULL
is	NULL
required	NULL
for	NULL
LPS	NULL
stimulation	NULL
of	NULL
TNF-	NULL
@	NULL
translation	NULL
:	NULL
glucocorticoids	NULL
inhibit	NULL
TNF-Q	NULL
@	NULL
translation	NULL
by	NULL
blocking	NULL
JNK/SAPK	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:6274-6282	NULL
.	NULL

31	NULL
.	NULL

Zhang	NULL
,	NULL
C.	NULL
,	NULL
Baumgartner	NULL
,	NULL
R.A.	NULL
,	NULL
Yamada	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Beaven	NULL
,	NULL
M.A	NULL
.	NULL

1997	NULL
.	NULL

MAPk	NULL
regulates	NULL
production	NULL
of	NULL
TNF-	NULL
@	NULL
and	NULL
release	NULL
of	NULL
arachidonic	NULL
acid	NULL
in	NULL
mast	NULL
cells	NULL
.	NULL

Indications	NULL
of	NULL
communication	NULL
between	NULL
p38	NULL
and	NULL
p42	NULL
MAPks	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:13397-13402	NULL
.	NULL

32	NULL
.	NULL

Young	NULL
,	NULL
P.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

Pyridinyl	NULL
imidazoles	NULL
inhibit	NULL
IL-1	NULL
and	NULL
TNF	NULL
production	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
.	NULL

Agents	NULL
Actions	NULL
.	NULL

39	NULL
:	NULL
C67-C69	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
-	NULL
|	NULL
March	NULL
1999	NULL
|	NULL
Volume	NULL
103	NULL
|_	NULL
Number	NULL
6	NULL

